WO2021085059A1 - Antiperspirant composition - Google Patents

Antiperspirant composition Download PDF

Info

Publication number
WO2021085059A1
WO2021085059A1 PCT/JP2020/037919 JP2020037919W WO2021085059A1 WO 2021085059 A1 WO2021085059 A1 WO 2021085059A1 JP 2020037919 W JP2020037919 W JP 2020037919W WO 2021085059 A1 WO2021085059 A1 WO 2021085059A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
antiperspirant
antiperspirant composition
examples
content
Prior art date
Application number
PCT/JP2020/037919
Other languages
French (fr)
Japanese (ja)
Inventor
愛 岡
智生 佐野
百合子 尾本
Original Assignee
ライオン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライオン株式会社 filed Critical ライオン株式会社
Priority to JP2021554246A priority Critical patent/JPWO2021085059A1/ja
Publication of WO2021085059A1 publication Critical patent/WO2021085059A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Definitions

  • the present invention relates to an antiperspirant composition.
  • an antiperspirant composition containing an antiperspirant component having an antiperspirant effect such as chlorohydroxyaluminum has been widely used (see, for example, Patent Document 1).
  • Chlorhydroxyaluminum exerts an antiperspirant effect by blocking the sweat glands with a plug, but when the amount of perspiration increases due to long-term sweating, there is a problem that the plug is eluted by sweat and the antiperspirant effect is lowered.
  • sufficient studies have not been conducted to prevent the elution of the plug due to sweat.
  • an antiperspirant composition containing an antiperspirant component such as chlorohydroxyaluminum an antiperspirant composition having a good feeling of tightness on the skin has been proposed (see Patent Document 2).
  • the proposed antiperspirant composition has a problem that the antiperspirant effect is not sufficiently satisfactory.
  • an antiperspirant composition having an excellent antiperspirant effect and lack of tension on the skin and having a good appearance of the agent has not yet been provided, and its rapid development is strongly desired at present. is there.
  • An object of the present invention is to solve the above-mentioned problems in the past and to achieve the following objects. That is, an object of the present invention is to provide an antiperspirant composition which is excellent in antiperspirant effect and lack of tension of the skin, and further has a good appearance of the agent.
  • the present inventors have at least one selected from (A) a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate.
  • the component (A) contains an antiperspirant component and (B) a water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a pair ion.
  • the antiperspirant composition as a means for solving the above-mentioned problems is (A) aluminum halide, aluminum halide hydrate, and halogen.
  • Water-soluble other than aluminum salt having at least one antiperspirant component selected from the complex of aluminum hydrate and (B) at least one selected from alkali metal ion, barium ion, and magnesium ion as pair ions. It contains a sex inorganic salt, and the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is 5 to 20.
  • an antiperspirant composition capable of solving the above-mentioned problems in the past, achieving the above-mentioned object, having an excellent antiperspirant effect and lack of tension on the skin, and having a good appearance of the agent. Can be provided.
  • the antiperspirant composition of the present invention comprises (A) at least one antiperspirant component selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate, and (B) a pair. It contains at least a water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ions, barium ions, and magnesium ions as ions, and further contains (C) an alkyl group having 1 to 4 carbon atoms.
  • D hydroxyalkylated cyclodextrin
  • E hydrated alkyl-modified alkyl cellulose
  • F at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid
  • G ethanol. It preferably contains at least one of them, and further contains other components as needed.
  • the antiperspirant component of the component (A) is not particularly limited as long as it is at least one selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate, and is not particularly limited. It can be appropriately selected accordingly.
  • Examples of the aluminum halide include aluminum chloride.
  • Examples of the halogenated aluminum hydrate include chlorohydroxyaluminum, bromohydroxyaluminum, chlorohydroxyaluminum / zirconium and the like.
  • Examples of the complex of aluminum halide hydrate include chlorohydroxyaluminum / propylene glycol complex, chlorohydroxyaluminum / zirconium-glycine complex and the like. These may be used alone or in combination of two or more. Among these, chlorohydroxyaluminum, chlorohydroxyaluminum / propylene glycol complex, and chlorohydroxyaluminum / zirconium-glycine complex are preferable because they are excellent in antiperspirant effect.
  • the antiperspirant component of the component (A) an appropriately synthesized one may be used, or a commercially available product may be used.
  • Commercially available products of the antiperspirant component of the component (A) include, for example, Aluminum (III) Chloride (manufactured by Tokyo Kasei Kogyo Co., Ltd., aluminum chloride) and a 50% aqueous solution of chlorohydroxyaluminum (Taki Chemical Co., Ltd.). , Chlorhydroxyaluminum), REHYDROL II (Clorhydroxyaluminum / propylene glycol complex manufactured by ELEMENTIS), Reach AZO-956G (Chlorhydroxyaluminum / zirconium-glycine complex manufactured by ELEMENTIS) and the like.
  • the content of the antiperspirant component of the component (A) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of the antiperspirant effect and the lack of tension of the skin, the antiperspirant. It is preferably 6% by mass to 15% by mass, more preferably 10% by mass to 15% by mass, based on the total amount of the composition. When the content of the component (A) is 6% by mass or more, the antiperspirant effect is good, and when it is 15% by mass or less, the skin does not feel taut.
  • a water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a counter ion of the component (B) is mainly contained to impart an antiperspirant effect. Will be done.
  • the water-soluble inorganic salt of the component (B) is not particularly limited as long as it is a water-soluble inorganic salt other than the aluminum salt, and can be appropriately selected depending on the intended purpose.
  • Examples include carbonates and hydrochlorides. These may be used alone or in combination of two or more. Among these, at least one selected from sulfates, carbonates, and hydrochlorides is preferable because it has an excellent antiperspirant effect.
  • the salt is at least one counterion selected from alkali metal ions, barium ions, and magnesium ions.
  • alkali metal ion include sodium ion and potassium ion.
  • the counterion is preferably sodium ion, potassium ion, or magnesium ion.
  • Examples of the sulfate include sodium sulfate, potassium sulfate, barium sulfate, magnesium sulfate and the like.
  • Examples of the carbonate include sodium carbonate, potassium carbonate, barium carbonate, magnesium carbonate and the like.
  • Examples of the bicarbonate include sodium bicarbonate, potassium bicarbonate and the like.
  • Examples of the hydrochloride include sodium chloride, potassium chloride, barium chloride, magnesium chloride and the like. Among these, even when the amount of perspiration increases due to long-term sweating, a strong plug that does not easily elute into sweat can be quickly formed, and the antiperspirant effect and the appearance of the agent can be improved. In that respect, sulfate is preferable, and sodium sulfate, potassium sulfate, magnesium sulfate, and barium sulfate are more preferable.
  • water-soluble inorganic salt other than the aluminum salt of the component (B) an appropriately synthesized one may be used, or a commercially available product may be used.
  • Commercially available products of water-soluble inorganic salts other than the aluminum salt of the component (B) include, for example, neutral anhydrous sodium sulfate (manufactured by Nippon Kagaku Kogyo Co., Ltd., anhydrous sodium sulfate) and anhydrous sodium sulfate (Tomita Pharmaceutical Co., Ltd.).
  • magnesium sulfate anhydrous (manufactured by Wako Pure Chemical Industries, Ltd.), sodium carbonate (manufactured by Takasugi Pharmaceutical Co., Ltd.), sodium chloride (manufactured by Genuine Chemical Co., Ltd.), etc.
  • the content of the water-soluble inorganic salt other than the aluminum salt of the component (B) is not particularly limited and may be appropriately selected depending on the intended purpose. It is preferably 0.6% by mass to 3.0% by mass, more preferably 0.8% by mass to 2.0% by mass, based on the total amount of the sweat agent composition. When the content of the component (B) is 0.6% by mass or more, the antiperspirant effect is good, and when it is 3.0% by mass or less, the antiperspirant effect and the appearance of the agent are good.
  • the mass ratio (A) / (B) of the content (mass%) of the component (A) to the content (mass%) of the component (B) is 5 from the viewpoint of antiperspirant effect and appearance of the agent. It is ⁇ 20, preferably 5-11. If the mass ratio (A) / (B) is less than 5, the antiperspirant effect and the appearance of the agent are insufficient, and if it exceeds 20, the antiperspirant effect is insufficient. On the other hand, when the mass ratio (A) / (B) is 5 to 20, it is advantageous in that the antiperspirant effect and the appearance of the agent are good.
  • the antiperspirant composition further comprises a monoalkyl maleate having an alkyl group having 1 to 4 carbon atoms and an alkyl group carbon as the component (C).
  • the antiperspirant composition contains a copolymer or a salt thereof containing at least one selected from alkylacrylamide, diacetoneacrylamide, vinylpyrrolidone, and ethylbetaine methacrylate as a monomer unit having a number of 1 to 8. It is also preferable in that it can impart a feeling of tightness to the skin.
  • the antiperspirant composition contains the component (C), it is preferable that the component (G) described later is further contained.
  • Examples of the copolymer containing monoalkyl maleate having 1 to 4 carbon atoms as a monomer unit or a salt thereof include (vinyl methyl ether / ethyl maleate) copolymer, (vinyl methyl ether / butyl maleate) copolymer and the like. Can be mentioned.
  • Examples of the copolymer containing alkylacrylamide having 1 to 8 carbon atoms as a monomer unit or a salt thereof of the alkyl group include (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer. Alternatively, the salt thereof and the like can be mentioned.
  • the "C” represents the number of carbon atoms of the alkyl group.
  • Examples of the copolymer containing diacetone acrylamide as a monomer unit or a salt thereof include a (Acrylate / diacetone acrylamide) copolymer or a salt thereof.
  • Examples of the copolymer containing vinylpyrrolidone as a monomer unit or a salt thereof include a (vinylpyrrolidone / vinyl acetate) copolymer and the like.
  • Examples of the copolymer containing ethyl betaine methacrylate as a monomer unit or a salt thereof include a (ethyl betaine methacrylate / acrylates) copolymer or a salt thereof.
  • the copolymer of the component (C) or a salt thereof may be used alone or in combination of two or more.
  • (vinyl methyl ether / ethyl maleate) copolymer, (vinyl methyl ether / butyl maleate) copolymer, (acrylamide / alkyl acrylate (C1-18) / alkyl) are excellent in that the skin does not feel taut.
  • a (C1-8) acrylamide) copolymer or a salt thereof, a (acrylics / diacetone acrylamide) copolymer or a salt thereof is more preferable.
  • the copolymer of the component (C) or a salt thereof may be used as it is, but the copolymer (unneutralized product) may be used.
  • a salt obtained by using an arbitrary alkaline agent may be used, or a salt (neutralized product) of the copolymer may be desalted with an arbitrary acid.
  • the alkaline agent is not particularly limited and may be appropriately selected depending on the intended purpose.
  • ammonium 2-amino-2-methyl-1-propanol (hereinafter, may be referred to as "AMP"), and the like.
  • Examples thereof include 2-amino-2-methyl-1,3-propanediol (hereinafter, may be referred to as "AMPD"). These may be used alone or in combination of two or more. Among these, AMP is preferable.
  • the acid is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include hydrochloric acid and sulfuric acid. These may be used alone or in combination of two or more.
  • the desalting method is not particularly limited and can be appropriately selected from known methods.
  • 1 g of the (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer AMP is dissolved in 4 g of 95 mass% ethanol, and 65 ⁇ L of hydrochloric acid is added thereto. And desalting to obtain a (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer.
  • copolymer of the component (C) or a salt thereof a synthetic product thereof may be used, or a commercially available product may be used.
  • Commercially available products of the copolymer of the component (C) or a salt thereof include, for example, Gantrez ES-225 (manufactured by Ashland Japan Co., Ltd., (vinyl methyl ether / ethyl maleate) copolymer), Gantrez.
  • the content of the copolymer of the component (C) or a salt thereof is not particularly limited and may be appropriately selected depending on the intended purpose, but has an antiperspirant effect, no skin tension, and appearance of the agent. From this point of view, 0.25% by mass to 1.5% by mass is preferable, and 0.5% by mass to 1.5% by mass is more preferable with respect to the total amount of the antiperspirant composition. When the content of the component (C) is 0.25% by mass or more, the antiperspirant effect and the lack of tension of the skin are good, and when it is 1.5% by mass or less, the appearance of the agent is good. ..
  • the hydroxyalkylated cyclodextrin of the component (D) is one in which a hydroxyalkyl group is introduced into a part of the hydroxyl groups of the cyclodextrin.
  • the cyclodextrin used as a raw material for the hydroxyalkylated cyclodextrin of the component (D) is not particularly limited and may be appropriately selected depending on the intended purpose.
  • the hydroxyalkylated cyclodextrin of the component (D) is made of a raw material containing one or more of these cyclodextrins.
  • the hydroxyalkyl group is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include substituents such as hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl.
  • the degree of substitution of the hydroxyalkyl group in the hydroxyalkylated cyclodextrin of the component (D) is not particularly limited and may be appropriately selected depending on the intended purpose, but from the viewpoint of solubility in water, 1 to 14 Is preferable.
  • hydroxyalkylated cyclodextrin of the component (D) include hydroxymethyl- ⁇ -cyclodextrin, hydroxymethyl- ⁇ -cyclodextrin, hydroxymethyl- ⁇ -cyclodextrin, hydroxyethyl- ⁇ -cyclodextrin, and hydroxy.
  • hydroxyalkylated cyclodextrin of the component (D) an appropriately synthesized one may be used, or a commercially available product may be used.
  • commercially available products of the hydroxyalkylated cyclodextrin of the component (D) include Celdex HP- ⁇ -CD (Nippon Shokuhin Kako Co., Ltd., hydroxypropyl- ⁇ -cyclodextrin) under the trade name.
  • the content of the hydroxyalkylated cyclodextrin of the component (D) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of deodorant effect and silky feeling, the total amount of the antiperspirant composition On the other hand, 0.1% by mass to 5.0% by mass is preferable, and 0.1% by mass to 2.5% by mass is more preferable. When the content of the component (D) is 0.1% by mass or more, the deodorizing effect is good, and when it is 5.0% by mass or less, the smooth feeling is good.
  • the antiperspirant composition further contains a hydrophobic alkyl-modified alkyl cellulose as a component (E), which imparts excellent non-stickiness after drying. It is preferable in that it can be used.
  • the hydrophobized alkyl-modified alkyl cellulose of the component (E) is not particularly limited and may be appropriately selected depending on the intended purpose. For example, dodecyloxyhydroxyalkyl cellulose (lauroxyhydroxyalkyl cellulose), tridecyloxyhydroxy.
  • hydrophobized alkyl-modified alkyl cellulose of the component (E) those synthesized as appropriate may be used, or commercially available products may be used.
  • Commercially available products of the hydrophobic alkyl-modified alkyl cellulose of the component (E) include, for example, Sangelose (registered trademark) 60L (manufactured by Daido Kasei Kogyo Co., Ltd., stearoxyhydroxypropyl methylcellulose) and Sangelose (registered).
  • the content of the hydrophobized alkyl-modified alkyl cellulose of the component (E) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of the appearance of the agent and the non-stickiness after drying, the above. It is preferably 0.1% by mass to 1% by mass, more preferably 0.1% by mass to 0.5% by mass, based on the total amount of the antiperspirant composition.
  • the content of the hydrophobized alkyl-modified alkyl cellulose of the component (E) is 0.1% by mass or more, the non-stickiness after drying is good, and when it is 1% by mass or less, the appearance of the agent is good. is there.
  • the mass ratio (B) / (E) of the content (mass%) of the component (B) to the content (mass%) of the component (E) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of high-temperature storage stability and natural appearance after drying, 2.1 to 10 is preferable, 3 to 8 is more preferable, and 3 to 5 is particularly preferable. When the mass ratio (B) / (E) is 2.1 or more, the high temperature storage stability is good, and when it is 10 or less, the high temperature storage stability and the natural appearance after drying are good.
  • the antiperspirant composition contains at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid as the component (F). It is preferable to include it in that it can impart excellent high temperature storage stability and natural appearance after drying, and it is preferable to include bisethoxydiglycolcyclohexanedicarboxylic acid in excellent high temperature storage stability and after drying. It is more preferable in that it can impart a natural appearance and non-stickiness after drying.
  • the present inventors further combine the component (C) with the component (E) and store the composition under high temperature (for example, 50 ° C.) conditions. In this case, the component (C) and the component (E) are precipitated, resulting in poor stability.
  • the present inventors diligently studied this problem, and by further blending the component (F), not only the storage stability under high temperature conditions is improved, but also the natural appearance after drying is improved. I found. Therefore, when the antiperspirant composition contains the component (C) and the component (E), it is preferable that the component (F) is further contained.
  • At least one selected from the bisethoxydiglycol succinate and the bisethoxydiglycol cyclohexanedicarboxylic acid of the component (F) may be appropriately synthesized or a commercially available product may be used.
  • Examples of commercially available products of the bisethoxydiglycol succinate of the component (F) include, under the trade name, High Aquos Star DCS (manufactured by Higher Alcohol Industry Co., Ltd.).
  • Examples of commercially available products of the cyclohexanedicarboxylic acid bisethoxydiglycol of the component (F) include Neosolue-Aquolio (manufactured by Nippon Fine Chemical Co., Ltd., cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol). Can be mentioned.
  • the content of at least one selected from the bisethoxydiglycol succinate and the bisethoxydiglycol cyclohexanedicarboxylic acid of the component (F) is not particularly limited and may be appropriately selected depending on the intended purpose. From the viewpoint of high-temperature storage stability, natural appearance after drying, and non-stickiness after drying, 0.1% by mass to 5% by mass is preferable, and 0.5% by mass, based on the total amount of the antiperspirant composition. More preferably, it is by mass% to 3% by mass.
  • the content of at least one selected from the bisethoxydiglycol succinate and the bisethoxydiglycol cyclohexanedicarboxylic acid of the component (F) is 0.1% by mass or more, the high temperature storage stability and the appearance after drying The naturalness of the mixture is good, and when it is 5% by mass or less, the non-stickiness after drying is good.
  • the antiperspirant composition contains ethanol as the component (G) in addition to the component (A) and the component (B) in that excellent high-temperature heat retention stability can be imparted.
  • the ethanol of the component (G) may be absolute ethanol or hydrous ethanol.
  • ethanol of the component (G) an appropriately synthesized ethanol may be used, or a commercially available product may be used.
  • commercially available products of the ethanol of the component (G) include synthetic alcohol 95 degrees (Japan Alcohol Trading Co., Ltd.) and 95 degree synthetic specified alcohol (manufactured by Shinwa Alcohol Corporation) under the trade name.
  • the content of ethanol of the component (G) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of high temperature storage stability, 20 is used with respect to the total amount of the antiperspirant composition. It is preferably mass% to 50% by mass, more preferably 25% by mass to 50% by mass. When the ethanol content of the component (G) is 20% by mass or more or 50% by mass or less, the high temperature storage stability is good. In addition, in this specification, the content of ethanol of the said component (G) is the content converted into absolute ethanol.
  • the antiperspirant composition may contain other components as long as the effects of the present invention are not impaired.
  • the other components are not particularly limited and may be appropriately selected depending on the intended purpose.
  • purified water, ion-exchanged water, pure water or solvent triclosan, isopropylmethylphenol, benzalconium chloride.
  • Bactericides such as: Nylon powder, polyethylene powder, silicic anhydride, silicone powder, cellulose powder, talc, kaolin, mica and other usability-enhancing powders; porous magnesia silica powder, synthetic layered magnesium pyrosilicate powder, etc.
  • Deodorant powders such as calcium alginate powder (secondary aggregate), apatite powder; preservatives such as methylparaben, ethylparaben, sodium benzoate; skin protectants such as bentonite and stearyl glycyrrhetinate; glycerin, hyaluronic acid Moisturizers such as urea; plant extracts such as aloe extract, eucalyptus extract, and white birch extract; viscosity modifiers such as hydroxypropyl cellulose and hydroxymethyl cellulose; urocanic acid, paraaminobenzoic acid, isopropyl paramethoxysilicate, hydroxymethoxybenzophenone UV absorbers such as; antioxidants such as tocophenol; refreshing agents such as menthol and menthyl lactate; pigments; fragrances and the like.
  • the content of the other components in the antiperspirant composition is not particularly limited as long as the effects of the present invention are not impaired
  • the pH of the antiperspirant composition at 25 ° C. is not particularly limited and may be appropriately selected depending on the intended purpose, but is 3.5 to 6.0 from the viewpoint of antiperspirant effect and appearance of the agent. preferable.
  • the viscosity of the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose. However, in the case of a liquid, from the viewpoint of antiperspirant effect, 1.0 mPa ⁇ s to 2 at 25 ° C. 000 mPa ⁇ s is preferable.
  • the viscosity of the antiperspirant composition was adjusted to 25 ° C., set in, for example, a BM type viscometer (using a No. 1 rotor or a No. 2 rotor), and the rotor was rotated at a rotation speed of 60 rpm. It can be measured 1 minute after the start of rotation of the rotor.
  • the dosage form of the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose.
  • Examples thereof include a liquid type, a solid type, a semi-solid type and a gel type.
  • the liquid type and the gel type are preferable, and the liquid type is preferable because it is effective to apply it to the skin in a state of being dissolved in water, and it can be applied with high adhesion and a high effect can be exhibited. Is more preferable.
  • Examples of the liquid type include a roll-on type, a mist spray type, a lotion type and the like.
  • Examples of the solid type include a stick type and a sheet type.
  • Examples of the semi-solid type include a cream type.
  • Examples of the gel-like type include a gel type.
  • the roll-on type is preferable from the viewpoint of antiperspirant effect.
  • the antiperspirant product comprises the antiperspirant composition and a roll-on container having a coating ball filled with the antiperspirant composition.
  • the roll-on type preparation is prepared in a ball in which the antiperspirant composition is housed in a known roll-on container, a part of the antiperspirant composition is exposed in the roll-on container, and the antiperspirant composition is rotatably held by a holder.
  • the antiperspirant composition can be applied to the skin by adhering the antiperspirant composition and adhering the ball to the skin at the time of use.
  • the antiperspirant composition is also suitable for a gel formulation in which the antiperspirant composition is filled in a bottle container and applied as it is using the container, a gel formulation applied using a fingertip or a hand, and a lotion formulation. Can be used for.
  • -container- Examples of the container that can be used for each of the above types include a roll-on container, a gel bottle container, a lotion bottle container, and a mist trigger type spray container.
  • a roll-on container is preferable from the viewpoint of ease of application to the skin.
  • the roll-on container can be suitably used because the antiperspirant composition can be applied to the skin with high adhesion and an antiperspirant effect can be exhibited.
  • the roll-on container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose.
  • the container described in JP-A-2005-186997. Bottle (Material: HDPE Natural, Fully filled content: Approx. 56 mL, Body diameter: Approx. 33 mm in diameter, Height: Approx. 87 mm, manufactured by Yoshino Kogyosho Co., Ltd.), Ring (Material: LLDPE Natural, Outer diameter: Approx.
  • the gel bottle container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose.
  • a bottle (trade name: TOMII, material: HDPE). Natural, full injection content: approx. 34 mL, body diameter: approx. 39 mm x 24 mm (oval), height: approx.
  • inner plug (trade name: TO cap nozzle B, material: PE Natural, outer diameter: about 12 mm, height: about 13 mm, manufactured by Takemoto Yohki Co., Ltd.), cap (trade name: TO cap, material: AS / PP white, outer diameter: diameter about 37 mm x 23 mm (oval), height : Approximately 22 mm, manufactured by Takemoto Yohki Co., Ltd.).
  • the lotion bottle container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose.
  • a bottle (trade name: TOMIII-50, material). : HDPE Natural, Fully filled content: Approximately 34 mL, Body diameter: Approximately 42 mm x 29 mm (oval), Height: Approximately 88 mm, manufactured by Takemoto Yohki Co., Ltd.), Inner plug (Product name: TO cap nozzle A, Material : PE natural, outer diameter: about 12 mm, height: about 13 mm, manufactured by Takemoto Yohki Co., Ltd.), cap (trade name: TOMIII cap, material: PP white, outer diameter: diameter about 37 mm x 25 mm (oval), height : Approximately 24 mm, manufactured by Takemoto Yohki Co., Ltd.).
  • the mist trigger container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose.
  • a bottle (trade name: PH-100, material). : PE Natural, Fully filled content: Approximately 100 mL, Body diameter: Approximately 40 mm in diameter, Height: Approximately 120 mm, manufactured by Kamimura Chemical Co., Ltd., Trigger (Product name: Z-305, Average diameter of spray hole: 0 A container made of .45 mm, manufactured by Mitani Valve Co., Ltd.) can be mentioned.
  • the method for producing the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose.
  • Ingredients and the other ingredients may be used alone in the preparation, or may be used in the preparation in the form of a mixture containing two or more kinds of ingredients.
  • the component (B) is added to water and uniformly dissolved, and then the component (A) is added and uniformly dissolved. Then, the component (D) and the component (E) are added and uniformly dissolved, and then the component (C) and the component (F) are uniformly dissolved and the component (G) is added. Examples thereof include a method of mixing and uniformly dissolving to obtain an antiperspirant composition.
  • the device for preparing the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose.
  • a plurality of stirring blades capable of shearing and total mixing are provided.
  • Such as a stirrer Such as a stirrer.
  • the antiperspirant composition of the present invention is excellent in antiperspirant effect and lack of tension on the skin, and has a good appearance, so that it can be widely used in cosmetics, pharmaceuticals, non-pharmaceutical products, etc. It can be preferably used by an antiperspirant, a deodorant, an antiperspirant deodorant, and a deodorant.
  • the content of each component described in Examples, Comparative Examples, and Formulation Examples is shown in% by mass, and all are values converted to pure content. Further, the mass ratio (A) / (B) of the content (mass%) of the component (A) to the content (mass%) of the component (B), and the content (mass%) of the component (B). The mass ratio (B) / (E) to the content (mass%) of the component (E) and (E) is described by rounding off the second digit after the decimal point to obtain the first digit after the decimal point. Further, as the ethanol of the component (G), synthetic alcohol 95 degrees (manufactured by Japan Alcohol Trading Co., Ltd.) was used, and the absolute ethanol conversion value (content (mass%) converted to absolute ethanol) was described.
  • Antiperspirant compositions having the compositions and contents shown in Tables 1 and 7 below were prepared by a conventional method. Specifically, after the component (B) was added to water and uniformly dissolved, the component (A) or the comparative component of the component (A) and the fragrance as a common component were added and uniformly dissolved in Examples. The antiperspirant compositions of 1 to 9 and Comparative Examples 1 to 5 were obtained.
  • Antiperspirant compositions having the composition and content shown in Table 2 below were prepared by a conventional method. Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, the component (G) and the fragrance as a common component were added, mixed and uniformly dissolved to obtain an antiperspirant composition of Examples 10 to 17. 40 mL of each of the obtained antiperspirant compositions of Examples 10 to 17 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
  • Antiperspirant compositions having the composition and content shown in Table 3 below were prepared by a conventional method. Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, the component (G) in which the component (C) was uniformly dissolved and the fragrance as a common component were added and mixed and uniformly dissolved to obtain an antiperspirant composition of Examples 18 to 25. 40 mL of each of the obtained antiperspirant compositions of Examples 18 to 25 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
  • Antiperspirant compositions having the composition and content shown in Table 4 below were prepared by a conventional method. Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, the component (D) was added and uniformly dissolved, and then the component (G) in which the component (C) was uniformly dissolved and the fragrance as a common component were added and mixed and uniformly dissolved.
  • the antiperspirant compositions of Examples 26-29 were obtained. 40 mL of each of the obtained antiperspirant compositions of Examples 26 to 29 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
  • Antiperspirant compositions having the compositions and contents shown in Tables 5 and 6 below were prepared by a conventional method. Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, after the component (E) was added and uniformly dissolved, the component (G) in which the components (C) and (F) were uniformly dissolved and the fragrance as a common component were added and mixed and uniformly dissolved. To obtain the antiperspirant compositions of Examples 30 to 41. 40 mL of each of the obtained antiperspirant compositions of Examples 30 to 41 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
  • Antiperspirant effect was evaluated from the average value of the antiperspirant rate based on the following evaluation criteria.
  • Antiperspirant rate (%) 100-Amount of perspiration in the area where the antiperspirant composition is applied / Amount of perspiration in the area where the antiperspirant composition is not applied x 100 ...
  • Equation (1) -Evaluation criteria for "antiperspirant effect"- ⁇ ⁇ : Average value of antiperspirant rate is 65% or more and 100% or less ⁇ : Average value of antiperspirant rate is 55% or more and less than 65% ⁇ : Average value of antiperspirant rate is 45% or more and less than 55% ⁇ : Antiperspirant Average rate is 10% or more and less than 45% ⁇ : Average antiperspirant rate is 0% or more and less than 10%
  • Antiperspirant compositions having the composition and content shown in Table 8 below were prepared by a conventional method. Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. After that, the components (D) and (E) were added and uniformly dissolved, and then the component (G) in which the components (C) and (F) were uniformly dissolved and the fragrance as a common component were added. It was added and mixed and uniformly dissolved to obtain an antiperspirant composition of Formulation Examples 1 to 5. 40 mL of each of the obtained antiperspirant compositions was filled in a roll-on container having the same specifications as in Examples 1 to 9 and Comparative Examples 1 to 5.
  • Examples of aspects of the present invention include the following. ⁇ 1>
  • A At least one antiperspirant component selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate.
  • B A water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a counter ion. Contains, The antiperspirant composition is characterized in that the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is 5 to 20.
  • ⁇ 2> Selected from monoalkyl maleate having 1 to 4 carbon atoms in the alkyl group, alkylacrylamide having 1 to 8 carbon atoms in the alkyl group, diacetoneacrylamide, vinylpyrrolidone, and ethylbetaine methacrylate.
  • the antiperspirant composition according to ⁇ 1> which further contains.
  • ⁇ 3> E) Hydrophobicized alkyl-modified alkyl cellulose, and (F) at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid.
  • the antiperspirant composition according to ⁇ 2> which further contains.
  • ⁇ 4> The antiperspirant composition according to ⁇ 3>, wherein the mass ratio (B) / (E) of the content of the component (B) to the content of the component (E) is 2.1 to 10. It is a thing.
  • ⁇ 5> The antiperspirant composition according to any one of ⁇ 1> to ⁇ 4>, which contains (D) hydroxyalkylated cyclodextrin.
  • ⁇ 6> The antiperspirant composition according to any one of ⁇ 1> to ⁇ 5>, wherein the component (B) is at least one selected from sulfate, carbonate, and hydrochloride.
  • the components (C) are (Acrylate / Diacetone Acrylamide) Copolymer AMP, (Acrylate / Alkyl Acrylate (C1-18) / Alkyl (C1-8) Acrylamide) Copolymer, and (Vinyl Methyl Ether / Ethyl Maleate).
  • the antiperspirant composition according to any one of ⁇ 2> to ⁇ 6>, which is at least one selected from the copolymer.
  • the antiperspirant composition of the present invention is excellent in antiperspirant effect and lack of tension on the skin, and has a good appearance, so that it can be widely used in cosmetics, pharmaceuticals, non-pharmaceutical products, and the like. It can be preferably used by an antiperspirant, a deodorant, an antiperspirant deodorant, and a deodorant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Provided is an antiperspirant composition containing: at least one antiperspirant component (A) selected from aluminum halides, aluminum halide hydrides, and complexes of aluminum halide hydrides; and a water-soluble inorganic salt (B) other than aluminum salts, the water-soluble inorganic salt having, as a counter ion, at least one selected from alkali metal ions, barium ion, and magnesium ion. The mass ratio (A)/(B) of the component (A) content to the component (B) content is 5-20.

Description

制汗剤組成物Antiperspirant composition
 本発明は、制汗剤組成物に関する。 The present invention relates to an antiperspirant composition.
 従来、クロルヒドロキシアルミニウムなどの制汗効果を有する制汗成分を配合した制汗剤組成物が広く使用されている(例えば、特許文献1参照)。
 クロルヒドロキシアルミニウムは汗腺をプラグで塞ぐことで制汗効果を発揮するが、長時間に及ぶ発汗により発汗量が増加すると、プラグが汗によって溶出し、その制汗効果が低下するといった課題がある。しかしながら、汗によるプラグの溶出を防止するための十分な検討は行われていない。
Conventionally, an antiperspirant composition containing an antiperspirant component having an antiperspirant effect such as chlorohydroxyaluminum has been widely used (see, for example, Patent Document 1).
Chlorhydroxyaluminum exerts an antiperspirant effect by blocking the sweat glands with a plug, but when the amount of perspiration increases due to long-term sweating, there is a problem that the plug is eluted by sweat and the antiperspirant effect is lowered. However, sufficient studies have not been conducted to prevent the elution of the plug due to sweat.
 また、クロルヒドロキシアルミニウムなどの制汗成分を配合した制汗剤組成物として、肌のつっぱり感のなさが良好である制汗剤組成物が提案されている(特許文献2参照)。しかしながら、この提案の制汗剤組成物は制汗効果が十分満足できるものではないという課題があった。 Further, as an antiperspirant composition containing an antiperspirant component such as chlorohydroxyaluminum, an antiperspirant composition having a good feeling of tightness on the skin has been proposed (see Patent Document 2). However, the proposed antiperspirant composition has a problem that the antiperspirant effect is not sufficiently satisfactory.
 また、クロルヒドロキシアルミニウムを配合した消臭効果の高い消臭用塗布剤も提案されている(特許文献3参照)。しかしながら、この提案の消臭用塗布剤は制汗効果が十分満足できるものではないだけでなく、配合成分の溶解性が悪いことにより、剤の外観が悪いという課題があった。 In addition, a deodorant coating agent containing chlorohydroxyaluminum and having a high deodorizing effect has also been proposed (see Patent Document 3). However, the deodorant coating agent of this proposal has a problem that not only the antiperspirant effect is not sufficiently satisfactory, but also the appearance of the agent is poor due to the poor solubility of the compounding components.
 したがって、制汗効果及び肌のつっぱり感のなさに優れ、更に剤の外観が良好である制汗剤組成物は未だ提供されておらず、その速やかな開発が強く望まれているのが現状である。 Therefore, an antiperspirant composition having an excellent antiperspirant effect and lack of tension on the skin and having a good appearance of the agent has not yet been provided, and its rapid development is strongly desired at present. is there.
特開2003-095906号公報Japanese Unexamined Patent Publication No. 2003-09596 特開2017-048140号公報Japanese Unexamined Patent Publication No. 2017-048140 特開平5-112440号公報Japanese Unexamined Patent Publication No. 5-112440
 本発明は、従来における前記諸問題を解決し、以下の目的を達成することを課題とする。即ち、本発明は、制汗効果及び肌のつっぱり感のなさに優れ、更に剤の外観が良好である制汗剤組成物を提供することを目的とする。 An object of the present invention is to solve the above-mentioned problems in the past and to achieve the following objects. That is, an object of the present invention is to provide an antiperspirant composition which is excellent in antiperspirant effect and lack of tension of the skin, and further has a good appearance of the agent.
 本発明者らは、前記目的を達成すべく鋭意検討を行った結果、(A)ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分と、(B)対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩と、を含有し、前記(A)成分の含有量と前記(B)成分の含有量との質量比(A)/(B)を5~20とすることにより、長時間に及ぶ発汗により発汗量が増加した場合であっても、前記制汗成分によるプラグは溶出せず制汗効果に優れること、また肌のつっぱり感のなさに優れること、更に剤の外観が良好となることを知見した。 As a result of diligent studies to achieve the above object, the present inventors have at least one selected from (A) a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate. The component (A) contains an antiperspirant component and (B) a water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a pair ion. By setting the mass ratio (A) / (B) of the content to the content of the component (B) to 5 to 20, even if the amount of sweating increases due to long-term sweating, the above-mentioned control It was found that the plug due to the sweat component does not elute and has an excellent antiperspirant effect, the skin does not feel taut, and the appearance of the agent is improved.
 本発明は、本発明者らによる前記知見に基づくものであり、前記課題を解決するための手段としての制汗剤組成物は、(A)ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分と、(B)対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩と、を含有し、前記(A)成分の含有量と前記(B)成分の含有量との質量比(A)/(B)が5~20である。 The present invention is based on the above findings by the present inventors, and the antiperspirant composition as a means for solving the above-mentioned problems is (A) aluminum halide, aluminum halide hydrate, and halogen. Water-soluble other than aluminum salt having at least one antiperspirant component selected from the complex of aluminum hydrate and (B) at least one selected from alkali metal ion, barium ion, and magnesium ion as pair ions. It contains a sex inorganic salt, and the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is 5 to 20.
 本発明によると、従来における前記諸問題を解決し、前記目的を達成することができ、制汗効果及び肌のつっぱり感のなさに優れ、更に剤の外観が良好である制汗剤組成物を提供することができる。 According to the present invention, an antiperspirant composition capable of solving the above-mentioned problems in the past, achieving the above-mentioned object, having an excellent antiperspirant effect and lack of tension on the skin, and having a good appearance of the agent. Can be provided.
(制汗剤組成物)
 本発明の制汗剤組成物は、(A)ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分と、(B)対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩と、を少なくとも含有し、更に、(C)アルキル基の炭素数が1~4のマレイン酸モノアルキル、アルキル基の炭素数が1~8のアルキルアクリルアミド、ジアセトンアクリルアミド、ビニルピロリドン、及びメタクリル酸エチルベタインから選択される少なくとも1種をモノマー単位として含む共重合体又はその塩、(D)ヒドロキシアルキル化シクロデキストリン、(E)疎水化アルキル変性アルキルセルロース、(F)コハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種、並びに(G)エタノールの少なくともいずれかを含有することが好ましく、必要に応じて更にその他の成分を含有する。
(Antiperspirant composition)
The antiperspirant composition of the present invention comprises (A) at least one antiperspirant component selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate, and (B) a pair. It contains at least a water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ions, barium ions, and magnesium ions as ions, and further contains (C) an alkyl group having 1 to 4 carbon atoms. A copolymer or a salt thereof containing at least one selected from monoalkyl maleate, alkylacrylamide having an alkyl group having 1 to 8 carbon atoms, diacetoneacrylamide, vinylpyrrolidone, and ethylbetaine methacrylate as a monomer unit. Of (D) hydroxyalkylated cyclodextrin, (E) hydrated alkyl-modified alkyl cellulose, (F) at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid, and (G) ethanol. It preferably contains at least one of them, and further contains other components as needed.
<(A)ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分>
 前記(A)成分のハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分は、主に、制汗効果を付与するために含有される。
<(A) At least one antiperspirant component selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate>
At least one antiperspirant component selected from the complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate as the component (A) is mainly used to impart an antiperspirant effect. It is contained.
 前記(A)成分の制汗成分としては、ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種である限り、特に制限はなく、目的に応じて適宜選択することができる。 The antiperspirant component of the component (A) is not particularly limited as long as it is at least one selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate, and is not particularly limited. It can be appropriately selected accordingly.
 前記ハロゲン化アルミニウムとしては、例えば、塩化アルミニウムなどが挙げられる。
 前記ハロゲン化アルミニウム水和物としては、例えば、クロルヒドロキシアルミニウム、ブロモヒドロキシアルミニウム、クロルヒドロキシアルミニウム/ジルコニウムなどが挙げられる。
 前記ハロゲン化アルミニウム水和物の錯体としては、例えば、クロルヒドロキシアルミニウム/プロピレングリコール錯体、クロルヒドロキシアルミニウム/ジルコニウム・グリシン錯体などが挙げられる。
 これらは、1種単独で使用してもよく、2種以上を併用してもよい。
 これらの中でも、制汗効果に優れる点で、クロルヒドロキシアルミニウム、クロルヒドロキシアルミニウム/プロピレングリコール錯体、クロルヒドロキシアルミニウム/ジルコニウム・グリシン錯体が好ましい。
Examples of the aluminum halide include aluminum chloride.
Examples of the halogenated aluminum hydrate include chlorohydroxyaluminum, bromohydroxyaluminum, chlorohydroxyaluminum / zirconium and the like.
Examples of the complex of aluminum halide hydrate include chlorohydroxyaluminum / propylene glycol complex, chlorohydroxyaluminum / zirconium-glycine complex and the like.
These may be used alone or in combination of two or more.
Among these, chlorohydroxyaluminum, chlorohydroxyaluminum / propylene glycol complex, and chlorohydroxyaluminum / zirconium-glycine complex are preferable because they are excellent in antiperspirant effect.
 前記(A)成分の制汗成分は、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(A)成分の制汗成分の市販品としては、例えば、商品名で、Aluminum(III)Chloride(東京化成工業株式会社製、塩化アルミニウム)、クロルヒドロキシアルミニウム50%水溶液(多木化学株式会社製、クロルヒドロキシアルミニウム)、REHYDROL II(ELEMENTIS社製、クロルヒドロキシアルミニウム/プロピレングリコール錯体)、Reach AZO-956G(ELEMENTIS社製、クロルヒドロキシアルミニウム/ジルコニウム・グリシン錯体)などが挙げられる。
As the antiperspirant component of the component (A), an appropriately synthesized one may be used, or a commercially available product may be used.
Commercially available products of the antiperspirant component of the component (A) include, for example, Aluminum (III) Chloride (manufactured by Tokyo Kasei Kogyo Co., Ltd., aluminum chloride) and a 50% aqueous solution of chlorohydroxyaluminum (Taki Chemical Co., Ltd.). , Chlorhydroxyaluminum), REHYDROL II (Clorhydroxyaluminum / propylene glycol complex manufactured by ELEMENTIS), Reach AZO-956G (Chlorhydroxyaluminum / zirconium-glycine complex manufactured by ELEMENTIS) and the like.
 前記(A)成分の制汗成分の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、制汗効果及び肌のつっぱり感のなさの点から、前記制汗剤組成物全量に対して、6質量%~15質量%が好ましく、10質量%~15質量%がより好ましい。前記(A)成分の含有量が、6質量%以上であると制汗効果が良好であり、15質量%以下であると肌のつっぱり感のなさが良好である。 The content of the antiperspirant component of the component (A) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of the antiperspirant effect and the lack of tension of the skin, the antiperspirant. It is preferably 6% by mass to 15% by mass, more preferably 10% by mass to 15% by mass, based on the total amount of the composition. When the content of the component (A) is 6% by mass or more, the antiperspirant effect is good, and when it is 15% by mass or less, the skin does not feel taut.
<(B)対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩>
 前記(B)成分の対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩は、主に、制汗効果を付与するために含有される。
<(B) A water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a counter ion>
A water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a counter ion of the component (B) is mainly contained to impart an antiperspirant effect. Will be done.
 前記(B)成分の水溶性無機塩としては、アルミニウム塩以外の水溶性無機塩である限り、特に制限はなく、目的に応じて適宜選択することができ、例えば、硫酸塩、炭酸塩、重炭酸塩、塩酸塩などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、制汗効果に優れる点で、硫酸塩、炭酸塩、及び塩酸塩から選択される少なくとも1種であることが好ましい。 The water-soluble inorganic salt of the component (B) is not particularly limited as long as it is a water-soluble inorganic salt other than the aluminum salt, and can be appropriately selected depending on the intended purpose. Examples include carbonates and hydrochlorides. These may be used alone or in combination of two or more. Among these, at least one selected from sulfates, carbonates, and hydrochlorides is preferable because it has an excellent antiperspirant effect.
 前記塩としては、対イオンが、アルカリ金属イオン、バリウムイオン、マグネシウムイオンから選択される少なくとも1種である。
 前記アルカリ金属イオンとしては、例えば、ナトリウムイオン、カリウムイオンなどが挙げられる。
 これらの中でも、前記対イオンは、ナトリウムイオン、カリウムイオン、マグネシウムイオンが好ましい。
The salt is at least one counterion selected from alkali metal ions, barium ions, and magnesium ions.
Examples of the alkali metal ion include sodium ion and potassium ion.
Among these, the counterion is preferably sodium ion, potassium ion, or magnesium ion.
 前記硫酸塩としては、例えば、硫酸ナトリウム、硫酸カリウム、硫酸バリウム、硫酸マグネシウムなどが挙げられる。
 前記炭酸塩としては、例えば、炭酸ナトリウム、炭酸カリウム、炭酸バリウム、炭酸マグネシウムなどが挙げられる。
 前記重炭酸塩としては、例えば、重炭酸ナトリウム、重炭酸カリウムなどが挙げられる。
 前記塩酸塩としては、例えば、塩化ナトリウム、塩化カリウム、塩化バリウム、塩化マグネシウムなどが挙げられる。
 これらの中でも、長時間に及ぶ発汗により発汗量が増加した場合であっても、汗に溶出しにくい強固なプラグを素早く形成することができ、制汗効果及び剤の外観が向上することができる点で、硫酸塩が好ましく、硫酸ナトリウム、硫酸カリウム、硫酸マグネシウム、硫酸バリウムがより好ましい。
Examples of the sulfate include sodium sulfate, potassium sulfate, barium sulfate, magnesium sulfate and the like.
Examples of the carbonate include sodium carbonate, potassium carbonate, barium carbonate, magnesium carbonate and the like.
Examples of the bicarbonate include sodium bicarbonate, potassium bicarbonate and the like.
Examples of the hydrochloride include sodium chloride, potassium chloride, barium chloride, magnesium chloride and the like.
Among these, even when the amount of perspiration increases due to long-term sweating, a strong plug that does not easily elute into sweat can be quickly formed, and the antiperspirant effect and the appearance of the agent can be improved. In that respect, sulfate is preferable, and sodium sulfate, potassium sulfate, magnesium sulfate, and barium sulfate are more preferable.
 前記(B)成分のアルミニウム塩以外の水溶性無機塩は、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(B)成分のアルミニウム塩以外の水溶性無機塩の市販品としては、例えば、商品名で、中性無水芒硝(日本化学工業株式会社製、無水硫酸ナトリウム)、無水硫酸ナトリウム(富田製薬株式会社)、硫酸マグネシウム(無水)(和光純薬工業株式会社製)、炭酸ナトリウム(高杉製薬株式会社製)、塩化ナトリウム(純正化学株式会社製)などが挙げられる。
As the water-soluble inorganic salt other than the aluminum salt of the component (B), an appropriately synthesized one may be used, or a commercially available product may be used.
Commercially available products of water-soluble inorganic salts other than the aluminum salt of the component (B) include, for example, neutral anhydrous sodium sulfate (manufactured by Nippon Kagaku Kogyo Co., Ltd., anhydrous sodium sulfate) and anhydrous sodium sulfate (Tomita Pharmaceutical Co., Ltd.). Company), magnesium sulfate (anhydrous) (manufactured by Wako Pure Chemical Industries, Ltd.), sodium carbonate (manufactured by Takasugi Pharmaceutical Co., Ltd.), sodium chloride (manufactured by Genuine Chemical Co., Ltd.), etc.
 前記(B)成分のアルミニウム塩以外の水溶性無機塩の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、制汗効果及び剤の外観の点から、前記制汗剤組成物全量に対して、0.6質量%~3.0質量%が好ましく、0.8質量%~2.0質量%がより好ましい。前記(B)成分の含有量が、0.6質量%以上であると制汗効果が良好であり、3.0質量%以下であると制汗効果及び剤の外観が良好である。 The content of the water-soluble inorganic salt other than the aluminum salt of the component (B) is not particularly limited and may be appropriately selected depending on the intended purpose. It is preferably 0.6% by mass to 3.0% by mass, more preferably 0.8% by mass to 2.0% by mass, based on the total amount of the sweat agent composition. When the content of the component (B) is 0.6% by mass or more, the antiperspirant effect is good, and when it is 3.0% by mass or less, the antiperspirant effect and the appearance of the agent are good.
<質量比(A)/(B)>
 前記(A)成分の含有量(質量%)と前記(B)成分の含有量(質量%)との質量比(A)/(B)は、制汗効果及び剤の外観の点から、5~20であり、5~11が好ましい。前記質量比(A)/(B)が、5未満であると、制汗効果及び剤の外観が不十分となり、20を超えると、制汗効果が不十分となる。一方、前記質量比(A)/(B)が5~20であると、制汗効果及び剤の外観が良好となる点で有利である。
<Mass ratio (A) / (B)>
The mass ratio (A) / (B) of the content (mass%) of the component (A) to the content (mass%) of the component (B) is 5 from the viewpoint of antiperspirant effect and appearance of the agent. It is ~ 20, preferably 5-11. If the mass ratio (A) / (B) is less than 5, the antiperspirant effect and the appearance of the agent are insufficient, and if it exceeds 20, the antiperspirant effect is insufficient. On the other hand, when the mass ratio (A) / (B) is 5 to 20, it is advantageous in that the antiperspirant effect and the appearance of the agent are good.
<(C)アルキル基の炭素数が1~4のマレイン酸モノアルキル、アルキル基の炭素数が1~8のアルキルアクリルアミド、ジアセトンアクリルアミド、ビニルピロリドン、及びメタクリル酸エチルベタインから選択される少なくとも1種をモノマー単位として含む共重合体又はその塩>
 前記制汗剤組成物は、前記(A)成分及び前記(B)成分に加えて、更に(C)成分としての、アルキル基の炭素数が1~4のマレイン酸モノアルキル、アルキル基の炭素数が1~8のアルキルアクリルアミド、ジアセトンアクリルアミド、ビニルピロリドン、及びメタクリル酸エチルベタインから選択される少なくとも1種をモノマー単位として含む共重合体又はその塩を含むことが、より優れた制汗効果及び肌のつっぱり感のなさを付与することができる点で好ましい。前記制汗剤組成物が前記(C)成分を含む場合、後述する(G)成分を更に含むことが好ましい。
<(C) At least one selected from monoalkyl maleate having 1 to 4 carbon atoms in the alkyl group, alkylacrylamide having 1 to 8 carbon atoms in the alkyl group, diacetoneacrylamide, vinylpyrrolidone, and ethylbetaine methacrylate. Copolymer containing seed as a monomer unit or a salt thereof>
In addition to the component (A) and the component (B), the antiperspirant composition further comprises a monoalkyl maleate having an alkyl group having 1 to 4 carbon atoms and an alkyl group carbon as the component (C). It is more excellent antiperspirant effect to contain a copolymer or a salt thereof containing at least one selected from alkylacrylamide, diacetoneacrylamide, vinylpyrrolidone, and ethylbetaine methacrylate as a monomer unit having a number of 1 to 8. It is also preferable in that it can impart a feeling of tightness to the skin. When the antiperspirant composition contains the component (C), it is preferable that the component (G) described later is further contained.
 前記炭素数が1~4のマレイン酸モノアルキルをモノマー単位として含む共重合体又はその塩としては、例えば、(ビニルメチルエーテル/マレイン酸エチル)コポリマー、(ビニルメチルエーテル/マレイン酸ブチル)コポリマーなどが挙げられる。 Examples of the copolymer containing monoalkyl maleate having 1 to 4 carbon atoms as a monomer unit or a salt thereof include (vinyl methyl ether / ethyl maleate) copolymer, (vinyl methyl ether / butyl maleate) copolymer and the like. Can be mentioned.
 前記アルキル基の炭素数が1~8のアルキルアクリルアミドをモノマー単位として含む共重合体又はその塩としては、例えば、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー又はその塩などが挙げられる。なお、前記「C」は、アルキル基の炭素数を表す。 Examples of the copolymer containing alkylacrylamide having 1 to 8 carbon atoms as a monomer unit or a salt thereof of the alkyl group include (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer. Alternatively, the salt thereof and the like can be mentioned. The "C" represents the number of carbon atoms of the alkyl group.
 前記ジアセトンアクリルアミドをモノマー単位として含む共重合体又はその塩としては、例えば、(アクリレーツ/ジアセトンアクリルアミド)コポリマー又はその塩などが挙げられる。 Examples of the copolymer containing diacetone acrylamide as a monomer unit or a salt thereof include a (Acrylate / diacetone acrylamide) copolymer or a salt thereof.
 前記ビニルピロリドンをモノマー単位として含む共重合体又はその塩としては、例えば、(ビニルピロリドン/酢酸ビニル)コポリマーなどが挙げられる。 Examples of the copolymer containing vinylpyrrolidone as a monomer unit or a salt thereof include a (vinylpyrrolidone / vinyl acetate) copolymer and the like.
 前記メタクリル酸エチルベタインをモノマー単位として含む共重合体又はその塩としては、例えば、(メタクリル酸エチルベタイン/アクリレーツ)コポリマー又はその塩などが挙げられる。 Examples of the copolymer containing ethyl betaine methacrylate as a monomer unit or a salt thereof include a (ethyl betaine methacrylate / acrylates) copolymer or a salt thereof.
 前記(C)成分の共重合体又はその塩は、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、肌のつっぱり感のなさに優れる点で、(ビニルメチルエーテル/マレイン酸エチル)コポリマー、(ビニルメチルエーテル/マレイン酸ブチル)コポリマー、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー又はその塩、(アクリレーツ/ジアセトンアクリルアミド)コポリマー又はその塩がより好ましい。 The copolymer of the component (C) or a salt thereof may be used alone or in combination of two or more. Among these, (vinyl methyl ether / ethyl maleate) copolymer, (vinyl methyl ether / butyl maleate) copolymer, (acrylamide / alkyl acrylate (C1-18) / alkyl) are excellent in that the skin does not feel taut. A (C1-8) acrylamide) copolymer or a salt thereof, a (acrylics / diacetone acrylamide) copolymer or a salt thereof is more preferable.
 前記(C)成分の共重合体又はその塩は、共重合体(未中和品)又はその塩(中和品)をそのまま用いてもよいが、前記共重合体(未中和品)を任意のアルカリ剤を用いて塩としたものを用いてもよく、前記共重合体の塩(中和品)を任意の酸を用いて脱塩したものを用いてもよい。 As the copolymer of the component (C) or a salt thereof, the copolymer (unneutralized product) or a salt thereof (neutralized product) may be used as it is, but the copolymer (unneutralized product) may be used. A salt obtained by using an arbitrary alkaline agent may be used, or a salt (neutralized product) of the copolymer may be desalted with an arbitrary acid.
 前記アルカリ剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、アンモニウム、2-アミノ-2-メチル-1-プロパノール(以下、「AMP」と称することがある)、2-アミノ-2-メチル-1,3-プロパンジオール(以下、「AMPD」と称することがある)などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、AMPが好ましい。 The alkaline agent is not particularly limited and may be appropriately selected depending on the intended purpose. For example, ammonium, 2-amino-2-methyl-1-propanol (hereinafter, may be referred to as "AMP"), and the like. Examples thereof include 2-amino-2-methyl-1,3-propanediol (hereinafter, may be referred to as "AMPD"). These may be used alone or in combination of two or more. Among these, AMP is preferable.
 前記酸としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、塩酸、硫酸などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。 The acid is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include hydrochloric acid and sulfuric acid. These may be used alone or in combination of two or more.
 前記脱塩の方法としては、特に制限はなく、公知の方法の中から適宜選択することができる。前記脱塩の方法の具体例としては、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマーAMP 1gを95質量%エタノール4gに溶解し、これに塩酸65μLを添加して脱塩し、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマーを得る方法などが挙げられる。 The desalting method is not particularly limited and can be appropriately selected from known methods. As a specific example of the desalting method, 1 g of the (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer AMP is dissolved in 4 g of 95 mass% ethanol, and 65 μL of hydrochloric acid is added thereto. And desalting to obtain a (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer.
 前記(C)成分の共重合体又はその塩は、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(C)成分の共重合体又はその塩の市販品としては、例えば、商品名で、ガントレッツES-225(アシュランド・ジャパン株式会社製、(ビニルメチルエーテル/マレイン酸エチル)コポリマー)、ガントレッツSP-215(アシュランド・ジャパン株式会社製、(ビニルメチルエーテル/マレイン酸エチル)コポリマー)、ガントレッツES-425(アシュランド・ジャパン株式会社製、(ビニルメチルエーテル/マレイン酸ブチル)コポリマー)、プラスサイズ L-9909B(互応化学工業株式会社製、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー)、プラスサイズ L-9909(互応化学工業株式会社製、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー)、プラスサイズ L-6740B(互応化学工業株式会社製、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー)、プラスサイズ L-6330(互応化学工業株式会社製、(アクリレーツ/ジアセトンアクリルアミド)コポリマーAMP)、PVP/VA S-630(アシュランド・ジャパン株式会社製、(ビニルピロリドン/酢酸ビニル)コポリマー)、ユカフォーマーR205S(三菱ケミカル株式会社製、(メタクリル酸エチルベタイン/アクリレーツ)コポリマー)などが挙げられる。
As the copolymer of the component (C) or a salt thereof, a synthetic product thereof may be used, or a commercially available product may be used.
Commercially available products of the copolymer of the component (C) or a salt thereof include, for example, Gantrez ES-225 (manufactured by Ashland Japan Co., Ltd., (vinyl methyl ether / ethyl maleate) copolymer), Gantrez. SP-215 (Ashland Japan Co., Ltd., (vinyl methyl ether / ethyl maleate) copolymer), Gantretz ES-425 (Ashland Japan Co., Ltd., (vinyl methyl ether / butyl maleate) copolymer), plus Size L-9909B (manufactured by Reciprocal Chemical Industry Co., Ltd., (Acrylate / alkyl acrylate (C1-18) / alkyl (C1-8) acrylamide) copolymer), plus size L-9909 (manufactured by Reciprocal Chemical Industry Co., Ltd., (Acrylates) / Alkyl acrylate (C1-18) / Alkyl (C1-8) acrylamide) copolymer), plus size L-6740B (manufactured by Reciprocal Chemical Industry Co., Ltd., (Acrylate / Alkyl acrylate (C1-18) / Alkyl (C1-18)) 8) acrylamide) copolymer), plus size L-6330 (manufactured by Reciprocal Chemical Industry Co., Ltd., (Acrylate / diacetone acrylamide) copolymer AMP), PVP / VA S-630 (manufactured by Ashland Japan Co., Ltd., (vinylpyrrolidone /) (Vinyl acetate) copolymer), Yukaformer R205S (manufactured by Mitsubishi Chemical Co., Ltd., (ethyl betaine methacrylate / Acrylate) copolymer) and the like.
 前記(C)成分の共重合体又はその塩の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、制汗効果、肌のつっぱり感のなさ、及び剤の外観の点から、前記制汗剤組成物全量に対して、0.25質量%~1.5質量%が好ましく、0.5質量%~1.5質量%がより好ましい。前記(C)成分の含有量が、0.25質量%以上であると制汗効果及び肌のつっぱり感のなさが良好であり、1.5質量%以下であると剤の外観が良好である。 The content of the copolymer of the component (C) or a salt thereof is not particularly limited and may be appropriately selected depending on the intended purpose, but has an antiperspirant effect, no skin tension, and appearance of the agent. From this point of view, 0.25% by mass to 1.5% by mass is preferable, and 0.5% by mass to 1.5% by mass is more preferable with respect to the total amount of the antiperspirant composition. When the content of the component (C) is 0.25% by mass or more, the antiperspirant effect and the lack of tension of the skin are good, and when it is 1.5% by mass or less, the appearance of the agent is good. ..
<(D)ヒドロキシアルキル化シクロデキストリン>
 前記制汗剤組成物は、前記(A)成分及び前記(B)成分に加えて、更に(D)成分としてのヒドロキシアルキル化シクロデキストリンを含むことが、優れた防臭効果を付与することができる点で好ましい。
<(D) Hydroxyalkylated cyclodextrin>
When the antiperspirant composition further contains hydroxyalkylated cyclodextrin as the component (D) in addition to the component (A) and the component (B), an excellent deodorant effect can be imparted. Preferable in terms of points.
 前記(D)成分のヒドロキシアルキル化シクロデキストリンは、シクロデキストリンの水酸基の一部にヒドロキシアルキル基を導入したものである。 The hydroxyalkylated cyclodextrin of the component (D) is one in which a hydroxyalkyl group is introduced into a part of the hydroxyl groups of the cyclodextrin.
 前記(D)成分のヒドロキシアルキル化シクロデキストリンの原料となる前記シクロデキストリンとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、α-シクロデキストリン、β-シクロデキストリン、γ-シクロデキストリンなどが挙げられる。これらは、構成されるグルコースの数が異なるものである。前記(D)成分のヒドロキシアルキル化シクロデキストリンは、これらのシクロデキストリンのうち1種若しくは2種以上を含む原料からなるものである。 The cyclodextrin used as a raw material for the hydroxyalkylated cyclodextrin of the component (D) is not particularly limited and may be appropriately selected depending on the intended purpose. For example, α-cyclodextrin, β-cyclodextrin, γ -Includes cyclodextrin and the like. These differ in the number of glucose constituents. The hydroxyalkylated cyclodextrin of the component (D) is made of a raw material containing one or more of these cyclodextrins.
 前記ヒドロキシアルキル基としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ヒドロキシメチル、ヒドロキシエチル、ヒドロキシプロピル、ヒドロキシブチル等の置換基などが挙げられる。 The hydroxyalkyl group is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include substituents such as hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl.
 前記(D)成分のヒドロキシアルキル化シクロデキストリンにおける前記ヒドロキシアルキル基の置換度としては、特に制限はなく、目的に応じて適宜選択することができるが、水への溶解性の点から1~14が好ましい。 The degree of substitution of the hydroxyalkyl group in the hydroxyalkylated cyclodextrin of the component (D) is not particularly limited and may be appropriately selected depending on the intended purpose, but from the viewpoint of solubility in water, 1 to 14 Is preferable.
 前記(D)成分のヒドロキシアルキル化シクロデキストリンの具体例としては、ヒドロキシメチル-α-シクロデキストリン、ヒドロキシメチル-β-シクロデキストリン、ヒドロキシメチル-γ-シクロデキストリン、ヒドロキシエチル-α-シクロデキストリン、ヒドロキシエチル-β-シクロデキストリン、ヒドロキシエチル-γ-シクロデキストリン、ヒドロキシプロピル-α-シクロデキストリン、ヒドロキシプロピル-β-シクロデキストリン、ヒドロキシプロピル-γ-シクロデキストリン、ヒドロキシブチル-α-シクロデキストリン、ヒドロキシブチル-β-シクロデキストリン、ヒドロキシブチル-γ-シクロデキストリンなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。
 これらの中でも、防臭効果や、価格、入手のしやすさの点で、ヒドロキシプロピル-β-シクロデキストリンが好ましい。
Specific examples of the hydroxyalkylated cyclodextrin of the component (D) include hydroxymethyl-α-cyclodextrin, hydroxymethyl-β-cyclodextrin, hydroxymethyl-γ-cyclodextrin, hydroxyethyl-α-cyclodextrin, and hydroxy. Ethyl-β-cyclodextrin, hydroxyethyl-γ-cyclodextrin, hydroxypropyl-α-cyclodextrin, hydroxypropyl-β-cyclodextrin, hydroxypropyl-γ-cyclodextrin, hydroxybutyl-α-cyclodextrin, hydroxybutyl- Examples thereof include β-cyclodextrin and hydroxybutyl-γ-cyclodextrin. These may be used alone or in combination of two or more.
Among these, hydroxypropyl-β-cyclodextrin is preferable in terms of deodorant effect, price, and availability.
 前記(D)成分のヒドロキシアルキル化シクロデキストリンは、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(D)成分のヒドロキシアルキル化シクロデキストリンの市販品としては、例えば、商品名で、セルデックスHP-β-CD(日本食品化工株式会社、ヒドロキシプロピル-β-シクロデキストリン)などが挙げられる。
As the hydroxyalkylated cyclodextrin of the component (D), an appropriately synthesized one may be used, or a commercially available product may be used.
Examples of commercially available products of the hydroxyalkylated cyclodextrin of the component (D) include Celdex HP-β-CD (Nippon Shokuhin Kako Co., Ltd., hydroxypropyl-β-cyclodextrin) under the trade name.
 前記(D)成分のヒドロキシアルキル化シクロデキストリンの含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、防臭効果及びさらさら感の点から、前記制汗剤組成物全量に対して、0.1質量%~5.0質量%が好ましく、0.1質量%~2.5質量%がより好ましい。前記(D)成分の含有量が、0.1質量%以上であると防臭効果が良好であり、5.0質量%以下であるとさらさら感が良好である。 The content of the hydroxyalkylated cyclodextrin of the component (D) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of deodorant effect and silky feeling, the total amount of the antiperspirant composition On the other hand, 0.1% by mass to 5.0% by mass is preferable, and 0.1% by mass to 2.5% by mass is more preferable. When the content of the component (D) is 0.1% by mass or more, the deodorizing effect is good, and when it is 5.0% by mass or less, the smooth feeling is good.
<(E)疎水化アルキル変性アルキルセルロース>
 前記制汗剤組成物は、前記(A)成分及び前記(B)成分に加えて、更に(E)成分として疎水化アルキル変性アルキルセルロースを含むことが、優れた乾燥後のべたつきのなさを付与することができる点で好ましい。
<(E) Hydrophobicized alkyl-modified alkyl cellulose>
In addition to the component (A) and the component (B), the antiperspirant composition further contains a hydrophobic alkyl-modified alkyl cellulose as a component (E), which imparts excellent non-stickiness after drying. It is preferable in that it can be used.
 前記(E)成分の疎水化アルキル変性アルキルセルロースとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ドデシロキシヒドロキシアルキルセルロース(ラウロキシヒドロキシアルキルセルロース)、トリデシロキシヒドロキシアルキルセルロース、テトラデシロキシヒドロキシアルキルセルロース(ミリスチロキシヒドロキシアルキルセルロース)、ペンタデシロキシヒドロキシアルキルセルロース、ヘキサデシロキシヒドロキシアルキルセルロース(セチロキシヒドロキシアルキルセルロース)、ヘプタデシロキシヒドロキシアルキルセルロース、オクタデシロキシヒドロキシアルキルセルロース(ステアロキシヒドロキシアルキルセルロース)、ノナデシロキシヒドロキシアルキルセルロース、エイコシロキシヒドロキシアルキルセルロース、ヘンエイコシロキシヒドロキシアルキルセルロース、ドコシロキシヒドロキシアルキルセルロースなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、乾燥後のべたつきのなさに優れる点で、オクタデシロキシヒドロキシプロピルメチルセルロース(ステアロキシヒドロキシプロピルメチルセルロース)が好ましい。 The hydrophobized alkyl-modified alkyl cellulose of the component (E) is not particularly limited and may be appropriately selected depending on the intended purpose. For example, dodecyloxyhydroxyalkyl cellulose (lauroxyhydroxyalkyl cellulose), tridecyloxyhydroxy. Alkyl Cellulose, Tetradecyloxy hydroxyalkyl Cellulose (Millistyroxy hydroxyalkyl Cellulose), Pentadecyloxy hydroxyalkyl Cellulose, Hexadecyloxy hydroxyalkyl Cellulose (Cetyroxy hydroxyalkyl Cellulose), Heptadecyloxy Hydroxyalkyl Cellulose, Octadesyloxy Hydroxyl Examples thereof include alkyl cellulose (stearoxy hydroxyalkyl cellulose), nonadesyloxy hydroxyalkyl cellulose, eikosyloxy hydroxyalkyl cellulose, henei cosyloxy hydroxyalkyl cellulose, docosyloxy hydroxyalkyl cellulose and the like. These may be used alone or in combination of two or more. Among these, octadecyloxyhydroxypropylmethylcellulose (stearoxyhydroxypropylmethylcellulose) is preferable because it is excellent in non-stickiness after drying.
 前記(E)成分の疎水化アルキル変性アルキルセルロースは、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(E)成分の疎水化アルキル変性アルキルセルロースの市販品としては、例えば、商品名で、サンジェロース(登録商標)60L(大同化成工業株式会社製、ステアロキシヒドロキシプロピルメチルセルロース)、サンジェロース(登録商標)60M(大同化成工業株式会社製、ステアロキシヒドロキシプロピルメチルセルロース)、サンジェロース(登録商標)90L(大同化成工業株式会社製、ステアロキシヒドロキシプロピルメチルセルロース)、サンジェロース(登録商標)90M(大同化成工業株式会社製、ステアロキシヒドロキシプロピルメチルセルロース)などが挙げられる。
As the hydrophobized alkyl-modified alkyl cellulose of the component (E), those synthesized as appropriate may be used, or commercially available products may be used.
Commercially available products of the hydrophobic alkyl-modified alkyl cellulose of the component (E) include, for example, Sangelose (registered trademark) 60L (manufactured by Daido Kasei Kogyo Co., Ltd., stearoxyhydroxypropyl methylcellulose) and Sangelose (registered). Trademark) 60M (manufactured by Daido Kasei Kogyo Co., Ltd., stearoxyhydroxypropylmethylcellulose), Sangelose (registered trademark) 90L (manufactured by Daido Kasei Kogyo Co., Ltd., stearoxyhydroxypropylmethylcellulose), Sangelose (registered trademark) 90M (registered trademark) Stearoxyhydroxypropylmethylcellulose, manufactured by Kogyo Co., Ltd.) and the like.
 前記(E)成分の疎水化アルキル変性アルキルセルロースの含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、剤の外観及び乾燥後のべたつきのなさの点から、前記制汗剤組成物全量に対して、0.1質量%~1質量%が好ましく、0.1質量%~0.5質量%がより好ましい。前記(E)成分の疎水化アルキル変性アルキルセルロースの含有量が、0.1質量%以上であると乾燥後のべたつきのなさが良好であり、1質量%以下であると剤の外観が良好である。 The content of the hydrophobized alkyl-modified alkyl cellulose of the component (E) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of the appearance of the agent and the non-stickiness after drying, the above. It is preferably 0.1% by mass to 1% by mass, more preferably 0.1% by mass to 0.5% by mass, based on the total amount of the antiperspirant composition. When the content of the hydrophobized alkyl-modified alkyl cellulose of the component (E) is 0.1% by mass or more, the non-stickiness after drying is good, and when it is 1% by mass or less, the appearance of the agent is good. is there.
<質量比(B)/(E)>
 前記(B)成分の含有量(質量%)と前記(E)成分の含有量(質量%)との質量比(B)/(E)としては、特に制限はなく、目的に応じて適宜選択することができるが、高温保存安定性及び乾燥後の見た目の自然さの点から、2.1~10が好ましく、3~8がより好ましく、3~5が特に好ましい。前記質量比(B)/(E)が、2.1以上であると高温保存安定性が良好であり、10以下であると高温保存安定性及び乾燥後の見た目の自然さが良好である。
<Mass ratio (B) / (E)>
The mass ratio (B) / (E) of the content (mass%) of the component (B) to the content (mass%) of the component (E) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of high-temperature storage stability and natural appearance after drying, 2.1 to 10 is preferable, 3 to 8 is more preferable, and 3 to 5 is particularly preferable. When the mass ratio (B) / (E) is 2.1 or more, the high temperature storage stability is good, and when it is 10 or less, the high temperature storage stability and the natural appearance after drying are good.
<(F)コハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種>
 前記制汗剤組成物は、前記(A)成分及び前記(B)成分に加えて、(F)成分としてコハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種を含むことが、優れた高温保存安定性及び乾燥後の見た目の自然さを付与することができる点で好ましく、シクロヘキサンジカルボン酸ビスエトキシジグリコールを含むことが、優れた高温保存安定性、乾燥後の見た目の自然さ、及び乾燥後のべたつきのなさを付与することができる点でより好ましい。
<(F) At least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid>
In addition to the component (A) and the component (B), the antiperspirant composition contains at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid as the component (F). It is preferable to include it in that it can impart excellent high temperature storage stability and natural appearance after drying, and it is preferable to include bisethoxydiglycolcyclohexanedicarboxylic acid in excellent high temperature storage stability and after drying. It is more preferable in that it can impart a natural appearance and non-stickiness after drying.
 本発明者らは、前記(B)成分を含有する制汗剤組成物において、更に前記(C)成分と、前記(E)成分とを組み合わせると、高温(例えば、50℃)条件下で保存した場合に、前記(C)成分及び前記(E)が析出してしまい、安定性が悪いという問題を見出した。本発明者らは、この問題について鋭意検討し、更に前記(F)成分を配合することで、高温条件下での保存安定性が向上するだけでなく、乾燥後の見た目の自然さも改善することを見出した。したがって、前記制汗剤組成物が、前記(C)成分及び前記(E)成分を含む場合、更に前記(F)成分を含むことが好ましい。 In the antiperspirant composition containing the component (B), the present inventors further combine the component (C) with the component (E) and store the composition under high temperature (for example, 50 ° C.) conditions. In this case, the component (C) and the component (E) are precipitated, resulting in poor stability. The present inventors diligently studied this problem, and by further blending the component (F), not only the storage stability under high temperature conditions is improved, but also the natural appearance after drying is improved. I found. Therefore, when the antiperspirant composition contains the component (C) and the component (E), it is preferable that the component (F) is further contained.
 前記(F)成分のコハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種は、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(F)成分のコハク酸ビスエトキシジグリコールの市販品としては、例えば、商品名で、ハイアクオスターDCS(高級アルコール工業株式会社製)などが挙げられる。
 前記(F)成分のシクロヘキサンジカルボン酸ビスエトキシジグリコールの市販品としては、例えば、商品名で、Neosolue-Aqulio(日本精化株式会社製、シクロヘキサン-1,4-ジカルボン酸ビスエトキシジグリコール)などが挙げられる。
At least one selected from the bisethoxydiglycol succinate and the bisethoxydiglycol cyclohexanedicarboxylic acid of the component (F) may be appropriately synthesized or a commercially available product may be used.
Examples of commercially available products of the bisethoxydiglycol succinate of the component (F) include, under the trade name, High Aquos Star DCS (manufactured by Higher Alcohol Industry Co., Ltd.).
Examples of commercially available products of the cyclohexanedicarboxylic acid bisethoxydiglycol of the component (F) include Neosolue-Aquolio (manufactured by Nippon Fine Chemical Co., Ltd., cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol). Can be mentioned.
 前記(F)成分のコハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、高温保存安定性、乾燥後の見た目の自然さ、及び乾燥後のべたつきのなさの点から、前記制汗剤組成物全量に対して、0.1質量%~5質量%が好ましく、0.5質量%~3質量%がより好ましい。前記(F)成分のコハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種の含有量が、0.1質量%以上であると高温保存安定性及び乾燥後の見た目の自然さが良好であり、5質量%以下であると乾燥後のべたつきのなさが良好である。 The content of at least one selected from the bisethoxydiglycol succinate and the bisethoxydiglycol cyclohexanedicarboxylic acid of the component (F) is not particularly limited and may be appropriately selected depending on the intended purpose. From the viewpoint of high-temperature storage stability, natural appearance after drying, and non-stickiness after drying, 0.1% by mass to 5% by mass is preferable, and 0.5% by mass, based on the total amount of the antiperspirant composition. More preferably, it is by mass% to 3% by mass. When the content of at least one selected from the bisethoxydiglycol succinate and the bisethoxydiglycol cyclohexanedicarboxylic acid of the component (F) is 0.1% by mass or more, the high temperature storage stability and the appearance after drying The naturalness of the mixture is good, and when it is 5% by mass or less, the non-stickiness after drying is good.
<(G)エタノール>
 前記制汗剤組成物は、前記(A)成分及び前記(B)成分に加えて、(G)成分としてエタノールを含むことが、優れた高温保温安定性を付与することができる点で好ましい。
 前記(G)成分のエタノールは、無水エタノールであってもよく、含水エタノールであってもよい。
<(G) Ethanol>
It is preferable that the antiperspirant composition contains ethanol as the component (G) in addition to the component (A) and the component (B) in that excellent high-temperature heat retention stability can be imparted.
The ethanol of the component (G) may be absolute ethanol or hydrous ethanol.
 前記(G)成分のエタノールは、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(G)成分のエタノールの市販品としては、例えば、商品名で、合成アルコール95度(日本アルコール販売株式会社)、95度合成特定アルコール(信和アルコール産業株式会社製)などが挙げられる。
As the ethanol of the component (G), an appropriately synthesized ethanol may be used, or a commercially available product may be used.
Examples of commercially available products of the ethanol of the component (G) include synthetic alcohol 95 degrees (Japan Alcohol Trading Co., Ltd.) and 95 degree synthetic specified alcohol (manufactured by Shinwa Alcohol Corporation) under the trade name.
 前記(G)成分のエタノールの含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、高温保存安定性の点から、前記制汗剤組成物全量に対して、20質量%~50質量%が好ましく、25質量%~50質量%がより好ましい。前記(G)成分のエタノールの含有量が、20質量%以上又は50質量%以下であると、高温保存安定性が良好である。なお、本明細書において、前記(G)成分のエタノールの含有量は、無水エタノールに換算した含有量である。 The content of ethanol of the component (G) is not particularly limited and may be appropriately selected depending on the intended purpose. However, from the viewpoint of high temperature storage stability, 20 is used with respect to the total amount of the antiperspirant composition. It is preferably mass% to 50% by mass, more preferably 25% by mass to 50% by mass. When the ethanol content of the component (G) is 20% by mass or more or 50% by mass or less, the high temperature storage stability is good. In addition, in this specification, the content of ethanol of the said component (G) is the content converted into absolute ethanol.
<その他の成分>
 前記制汗剤組成物は、前記(A)成分~前記(G)成分の各成分以外にも、本発明の効果を損なわない範囲で、その他の成分を配合することができる。前記その他の成分としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、精製水、イオン交換水、純粋等の水又溶剤;トリクロサン、イソプロピルメチルフェノール、ベンザルコニウム塩化物等の殺菌剤;ナイロン末、ポリエチレン末、無水ケイ酸、シリコーンパウダー、セルロース粉体、タルク、カオリン、マイカ等の使用性向上粉体;多孔質マグネシアシリカ粉体、合成層状ピロケイ酸マグネシウム粉体、アルギン酸カルシウム粉体(2次凝集物)、アパタイト粉体等の消臭粉体;メチルパラベン、エチルパラベン、安息香酸ナトリウム類等の防腐剤;ベントナイト、グリチルレチン酸ステアリル等の皮膚保護剤;グリセリン、ヒアルロン酸、尿素等の保湿剤;アロエエキス、ユーカリエキス、シラカバエキス等の植物抽出エキス;ヒドロキシプロピルセルロース、ヒドロキシメチルセルロース等の粘度調整剤;ウロカニン酸、パラアミノ安息香酸、パラメトキシケイ皮酸イソプロピル、ヒドロキシメトキシベンゾフェノン等の紫外線吸収剤;トコフェノール等の抗酸化剤;メントール、乳酸メンチル等の清涼剤;顔料;香料などが挙げられる。
 前記その他の成分の前記制汗剤組成物における含有量としては、本発明の効果を損なわない限り、特に制限はなく、目的に応じて適宜選択することができる。
<Other ingredients>
In addition to each of the components (A) to (G), the antiperspirant composition may contain other components as long as the effects of the present invention are not impaired. The other components are not particularly limited and may be appropriately selected depending on the intended purpose. For example, purified water, ion-exchanged water, pure water or solvent; triclosan, isopropylmethylphenol, benzalconium chloride. Bactericides such as: Nylon powder, polyethylene powder, silicic anhydride, silicone powder, cellulose powder, talc, kaolin, mica and other usability-enhancing powders; porous magnesia silica powder, synthetic layered magnesium pyrosilicate powder, etc. Deodorant powders such as calcium alginate powder (secondary aggregate), apatite powder; preservatives such as methylparaben, ethylparaben, sodium benzoate; skin protectants such as bentonite and stearyl glycyrrhetinate; glycerin, hyaluronic acid Moisturizers such as urea; plant extracts such as aloe extract, eucalyptus extract, and white birch extract; viscosity modifiers such as hydroxypropyl cellulose and hydroxymethyl cellulose; urocanic acid, paraaminobenzoic acid, isopropyl paramethoxysilicate, hydroxymethoxybenzophenone UV absorbers such as; antioxidants such as tocophenol; refreshing agents such as menthol and menthyl lactate; pigments; fragrances and the like.
The content of the other components in the antiperspirant composition is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately selected depending on the intended purpose.
-pH-
 前記制汗剤組成物の25℃におけるpHとしては、特に制限はなく、目的に応じて適宜選択することができるが、制汗効果及び剤の外観の点から、3.5~6.0が好ましい。
-PH-
The pH of the antiperspirant composition at 25 ° C. is not particularly limited and may be appropriately selected depending on the intended purpose, but is 3.5 to 6.0 from the viewpoint of antiperspirant effect and appearance of the agent. preferable.
-粘度-
 前記制汗剤組成物の粘度としては、特に制限はなく、目的に応じて適宜選択することができるが、液状の場合、制汗効果の点から、25℃において、1.0mPa・s~2,000mPa・sが好ましい。
-viscosity-
The viscosity of the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose. However, in the case of a liquid, from the viewpoint of antiperspirant effect, 1.0 mPa · s to 2 at 25 ° C. 000 mPa · s is preferable.
 前記粘度は、前記制汗剤組成物を25℃に調温し、例えば、BM型粘度計(No.1ローター又はNo.2ローターを使用)にセットし、ローターを回転数60rpmで回転させ、ローターの回転開始から1分間後に測定することができる。 The viscosity of the antiperspirant composition was adjusted to 25 ° C., set in, for example, a BM type viscometer (using a No. 1 rotor or a No. 2 rotor), and the rotor was rotated at a rotation speed of 60 rpm. It can be measured 1 minute after the start of rotation of the rotor.
-剤型-
 前記制汗剤組成物の剤型としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、液状タイプ、固形状タイプ、半固形状タイプ、ジェル状タイプなどが挙げられる。これらの中でも、水分に溶解した状態で肌に塗布されることが効果発現に有効であり、また高密着に塗布でき、高い効果が発現できる点から、液状タイプ、ジェル状タイプが好ましく、液状タイプがより好ましい。
-Dosage form-
The dosage form of the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include a liquid type, a solid type, a semi-solid type and a gel type. Among these, the liquid type and the gel type are preferable, and the liquid type is preferable because it is effective to apply it to the skin in a state of being dissolved in water, and it can be applied with high adhesion and a high effect can be exhibited. Is more preferable.
 前記液状タイプとしては、例えば、ロールオンタイプ、ミストスプレータイプ、ローションタイプなどが挙げられる。
 前記固形状タイプとしては、例えば、スティックタイプ、シートタイプなどが挙げられる。
 前記半固形状タイプとしては、例えば、クリームタイプなどが挙げられる。
 前記ジェル状タイプとしては、例えば、ジェルタイプなどが挙げられる。
 これらの中でも、制汗効果の点から、ロールオンタイプが好ましい。
Examples of the liquid type include a roll-on type, a mist spray type, a lotion type and the like.
Examples of the solid type include a stick type and a sheet type.
Examples of the semi-solid type include a cream type.
Examples of the gel-like type include a gel type.
Among these, the roll-on type is preferable from the viewpoint of antiperspirant effect.
 前記制汗剤組成物をロールオンタイプとする場合は、前記制汗剤組成物と、該制汗剤組成物を充填した塗布ボールを有するロールオン容器とからなる制汗剤製品とすることが好ましい。前記ロールオンタイプの製剤は、前記制汗剤組成物が公知のロールオン容器に収容され、前記ロールオン容器にその一部が露出した状態、かつ、回転可能にホルダーで保持された状態のボールに前記制汗剤組成物を付着させ、使用時に前記ボールを肌に付着させることにより、前記制汗剤組成物を肌に塗布することができる。
 また、前記制汗剤組成物は、該制汗剤組成物をボトル容器に充填し、容器を用いてそのまま塗布するジェル製剤、指先や手を使用して塗布するジェル製剤、ローション製剤にも好適に用いることができる。
When the antiperspirant composition is a roll-on type, it is preferable that the antiperspirant product comprises the antiperspirant composition and a roll-on container having a coating ball filled with the antiperspirant composition. The roll-on type preparation is prepared in a ball in which the antiperspirant composition is housed in a known roll-on container, a part of the antiperspirant composition is exposed in the roll-on container, and the antiperspirant composition is rotatably held by a holder. The antiperspirant composition can be applied to the skin by adhering the antiperspirant composition and adhering the ball to the skin at the time of use.
The antiperspirant composition is also suitable for a gel formulation in which the antiperspirant composition is filled in a bottle container and applied as it is using the container, a gel formulation applied using a fingertip or a hand, and a lotion formulation. Can be used for.
-容器-
 前記各タイプに用いることができる容器としては、例えば、ロールオン容器、ジェル用ボトル容器、ローション用ボトル容器、ミスト用トリガー型スプレー容器などが挙げられる。これらの中でも、肌への塗りやすさの点から、ロールオン容器が好ましい。前記ロールオン容器は、前記制汗剤組成物を肌に高密着に塗布でき、制汗効果を発現できる点で好適に使用できる。
-container-
Examples of the container that can be used for each of the above types include a roll-on container, a gel bottle container, a lotion bottle container, and a mist trigger type spray container. Among these, a roll-on container is preferable from the viewpoint of ease of application to the skin. The roll-on container can be suitably used because the antiperspirant composition can be applied to the skin with high adhesion and an antiperspirant effect can be exhibited.
 前記ロールオン容器としては、前記制汗剤組成物を充填できるものであれば、特に制限はなく、目的に応じて適宜選択することができ、例えば、特開2005-186997号公報に記載された容器;ボトル(材質:HDPEナチュラル、満注内容量:約56mL、胴径:直径約33mm、高さ:約87mm、株式会社吉野工業所製)、リング(材質:LLDPEナチュラル、外径:約26mm、高さ:約18mm、株式会社吉野工業所製)、ボール(材質:PPホワイト、直径:約20mm、株式会社吉野工業所製)からなる容器などが挙げられる。 The roll-on container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose. For example, the container described in JP-A-2005-186997. Bottle (Material: HDPE Natural, Fully filled content: Approx. 56 mL, Body diameter: Approx. 33 mm in diameter, Height: Approx. 87 mm, manufactured by Yoshino Kogyosho Co., Ltd.), Ring (Material: LLDPE Natural, Outer diameter: Approx. 26 mm, Height: about 18 mm, manufactured by Yoshino Kogyosho Co., Ltd.), balls (material: PP white, diameter: about 20 mm, manufactured by Yoshino Kogyosho Co., Ltd.), and the like.
 前記ジェル用ボトル容器としては、前記制汗剤組成物を充填できるものであれば、特に制限はなく、目的に応じて適宜選択することができ、例えば、ボトル(商品名:TOMII、材質:HDPEナチュラル、満注内容量:約34mL、胴径:直径約39mm×24mm(オーバル)、高さ:約76mm、竹本容器株式会社製)、中栓(商品名:TOキャップ用ノズルB、材質:PEナチュラル、外径:約12mm、高さ:約13mm、竹本容器株式会社製)、キャップ(商品名:TOキャップ、材質:AS/PPホワイト、外径:直径約37mm×23mm(オーバル)、高さ:約22mm、竹本容器株式会社製)からなる容器などが挙げられる。 The gel bottle container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose. For example, a bottle (trade name: TOMII, material: HDPE). Natural, full injection content: approx. 34 mL, body diameter: approx. 39 mm x 24 mm (oval), height: approx. 76 mm, manufactured by Takemoto Yohki Co., Ltd.), inner plug (trade name: TO cap nozzle B, material: PE Natural, outer diameter: about 12 mm, height: about 13 mm, manufactured by Takemoto Yohki Co., Ltd.), cap (trade name: TO cap, material: AS / PP white, outer diameter: diameter about 37 mm x 23 mm (oval), height : Approximately 22 mm, manufactured by Takemoto Yohki Co., Ltd.).
 前記ローション用ボトル容器としては、前記制汗剤組成物を充填できるものであれば、特に制限はなく、目的に応じて適宜選択することができ、例えば、ボトル(商品名:TOMIII-50、材質:HDPEナチュラル、満注内容量:約34mL、胴径:直径約42mm×29mm(オーバル)、高さ:約88mm、竹本容器株式会社製)、中栓(商品名:TOキャップ用ノズルA、材質:PEナチュラル、外径:約12mm、高さ:約13mm、竹本容器株式会社製)、キャップ(商品名:TOMIIIキャップ、材質:PPホワイト、外径:直径約37mm×25mm(オーバル)、高さ:約24mm、竹本容器株式会社製)からなる容器などが挙げられる。 The lotion bottle container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose. For example, a bottle (trade name: TOMIII-50, material). : HDPE Natural, Fully filled content: Approximately 34 mL, Body diameter: Approximately 42 mm x 29 mm (oval), Height: Approximately 88 mm, manufactured by Takemoto Yohki Co., Ltd.), Inner plug (Product name: TO cap nozzle A, Material : PE natural, outer diameter: about 12 mm, height: about 13 mm, manufactured by Takemoto Yohki Co., Ltd.), cap (trade name: TOMIII cap, material: PP white, outer diameter: diameter about 37 mm x 25 mm (oval), height : Approximately 24 mm, manufactured by Takemoto Yohki Co., Ltd.).
 前記ミスト用トリガー容器としては、前記制汗剤組成物を充填できるものであれば、特に制限はなく、目的に応じて適宜選択することができ、例えば、ボトル(商品名:PH-100、材質:PEナチュラル、満注内容量:約100mL、胴径:直径約40mm、高さ:約120mm、かみむら化学株式会社製)、トリガー(商品名:Z-305、スプレー孔部の平均径:0.45mm、株式会社三谷バルブ製)からなる容器などが挙げられる。 The mist trigger container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected depending on the intended purpose. For example, a bottle (trade name: PH-100, material). : PE Natural, Fully filled content: Approximately 100 mL, Body diameter: Approximately 40 mm in diameter, Height: Approximately 120 mm, manufactured by Kamimura Chemical Co., Ltd., Trigger (Product name: Z-305, Average diameter of spray hole: 0 A container made of .45 mm, manufactured by Mitani Valve Co., Ltd.) can be mentioned.
-製造方法-
 前記制汗剤組成物の製造方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、前記(A)成分及び前記(B)成分、好ましくは、前記(C)成分、前記(D)成分、前記(E)成分、前記(F)成分、及び前記(G)成分の少なくともいずれか、更に必要に応じて、前記その他の成分、及び水(制汗剤組成物の全体が100質量%となるように残量配合)を混合して製造することができる。前記制汗剤組成物を製造するにあたり、前記(A)成分、前記(B)成分、前記(C)成分、前記(D)成分、前記(E)成分、前記(F)成分、前記(G)成分、及び前記その他の成分は、それぞれ単独で調製に用いられてもよく、2種以上の成分を含む混合物の状態で調製に用いられてもよい。
-Production method-
The method for producing the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose. For example, the component (A) and the component (B), preferably the component (C). , The (D) component, the (E) component, the (F) component, and at least one of the (G) components, and if necessary, the other components, and water (antiperspirant composition). It can be produced by mixing (the remaining amount is mixed) so that the whole becomes 100% by mass. In producing the antiperspirant composition, the component (A), the component (B), the component (C), the component (D), the component (E), the component (F), and the component (G). ) Ingredients and the other ingredients may be used alone in the preparation, or may be used in the preparation in the form of a mixture containing two or more kinds of ingredients.
 前記制汗剤組成物の製造方法の具体例としては、水に前記(B)成分を投入して均一溶解させた後、前記(A)成分を投入し、均一に溶解する。その後、前記(D)成分及び前記(E)成分を投入し、均一に溶解させた後、前記(C)成分及び前記(F)成分を均一に溶解させた前記(G)成分を投入して混合及び均一に溶解して制汗剤組成物を得る方法が挙げられる。 As a specific example of the method for producing the antiperspirant composition, the component (B) is added to water and uniformly dissolved, and then the component (A) is added and uniformly dissolved. Then, the component (D) and the component (E) are added and uniformly dissolved, and then the component (C) and the component (F) are uniformly dissolved and the component (G) is added. Examples thereof include a method of mixing and uniformly dissolving to obtain an antiperspirant composition.
 前記制汗剤組成物を調製する装置としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、剪断と全体混合できる複数の撹拌羽根(プロペラ、タービン、ディスパー等)を備えた撹拌装置などが挙げられる。 The device for preparing the antiperspirant composition is not particularly limited and may be appropriately selected depending on the intended purpose. For example, a plurality of stirring blades (propeller, turbine, disper, etc.) capable of shearing and total mixing are provided. Such as a stirrer.
-用途-
 本発明の制汗剤組成物は、制汗効果及び肌のつっぱり感のなさに優れ、更に剤の外観が良好であるため、化粧料、医薬品、医薬部外品等に幅広く用いることができ、制汗剤、防臭剤、制汗防臭剤、デオドラント剤により好適に用いることができる。
-Use-
The antiperspirant composition of the present invention is excellent in antiperspirant effect and lack of tension on the skin, and has a good appearance, so that it can be widely used in cosmetics, pharmaceuticals, non-pharmaceutical products, etc. It can be preferably used by an antiperspirant, a deodorant, an antiperspirant deodorant, and a deodorant.
 以下に実施例、比較例、及び処方例を挙げて本発明を具体的に説明するが、本発明はこれらの実施例及び処方例に何ら限定されるものではない。 Hereinafter, the present invention will be specifically described with reference to Examples, Comparative Examples, and Formulation Examples, but the present invention is not limited to these Examples and Formulation Examples.
 実施例、比較例、及び処方例に記載の各成分の含有量は質量%で示し、全て純分換算した値である。また、(A)成分の含有量(質量%)と前記(B)成分の含有量(質量%)との質量比(A)/(B)、及び(B)成分の含有量(質量%)と(E)成分の含有量(質量%)との質量比(B)/(E)は、小数点以下第2位を四捨五入し、小数点以下第1位まで求め、記載した。また、(G)成分のエタノールは、合成アルコール95度(日本アルコール販売株式会社製)を使用し、無水エタノール換算値(無水エタノールに換算した含有量(質量%))を記載した。 The content of each component described in Examples, Comparative Examples, and Formulation Examples is shown in% by mass, and all are values converted to pure content. Further, the mass ratio (A) / (B) of the content (mass%) of the component (A) to the content (mass%) of the component (B), and the content (mass%) of the component (B). The mass ratio (B) / (E) to the content (mass%) of the component (E) and (E) is described by rounding off the second digit after the decimal point to obtain the first digit after the decimal point. Further, as the ethanol of the component (G), synthetic alcohol 95 degrees (manufactured by Japan Alcohol Trading Co., Ltd.) was used, and the absolute ethanol conversion value (content (mass%) converted to absolute ethanol) was described.
(実施例1~9及び比較例1~5)
 下記表1及び表7に示す組成及び含有量の制汗剤組成物を常法により調製した。
 具体的には、水に(B)成分を投入して均一溶解させた後、(A)成分又は(A)成分の比較成分及び共通成分としての香料を投入し、均一に溶解して実施例1~9及び比較例1~5の制汗剤組成物を得た。
(Examples 1 to 9 and Comparative Examples 1 to 5)
Antiperspirant compositions having the compositions and contents shown in Tables 1 and 7 below were prepared by a conventional method.
Specifically, after the component (B) was added to water and uniformly dissolved, the component (A) or the comparative component of the component (A) and the fragrance as a common component were added and uniformly dissolved in Examples. The antiperspirant compositions of 1 to 9 and Comparative Examples 1 to 5 were obtained.
 得られた実施例1~9及び比較例1~5の各制汗剤組成物を、下記仕様のロールオン容器に40mL充填した。
-ロールオン容器-
 ・ ボトル(材質:HDPE ナチュラル、満注内容量:約56mL、胴径:直径約33mm、高さ:約87mm、株式会社吉野工業所製)
 ・ リング(材質:LLDPE ナチュラル、外径:約26mm、高さ:約18mm、株式会社吉野工業所製)
 ・ ボール(材質:PP ホワイト、直径:約20mm、株式会社吉野工業所製)
40 mL of each of the obtained antiperspirant compositions of Examples 1 to 9 and Comparative Examples 1 to 5 was filled in a roll-on container having the following specifications.
-Roll-on container-
・ Bottle (Material: HDPE Natural, Fully filled content: Approximately 56 mL, Body diameter: Approximately 33 mm in diameter, Height: Approximately 87 mm, manufactured by Yoshino Kogyosho Co., Ltd.)
・ Ring (Material: LLDPE Natural, Outer diameter: Approx. 26 mm, Height: Approx. 18 mm, manufactured by Yoshino Kogyosho Co., Ltd.)
・ Ball (Material: PP white, diameter: about 20 mm, manufactured by Yoshino Kogyosho Co., Ltd.)
(実施例10~17)
 下記表2に示す組成及び含有量の制汗剤組成物を常法により調製した。
 具体的には、水に(B)成分を投入して均一溶解させた後、(A)成分を投入し、均一に溶解した。その後、(G)成分及び共通成分としての香料を投入して混合及び均一に溶解して実施例10~17の制汗剤組成物を得た。
 得られた実施例10~17の各制汗剤組成物は、実施例1~9及び比較例1~5と同様の仕様のロールオン容器に40mL充填した。
(Examples 10 to 17)
Antiperspirant compositions having the composition and content shown in Table 2 below were prepared by a conventional method.
Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, the component (G) and the fragrance as a common component were added, mixed and uniformly dissolved to obtain an antiperspirant composition of Examples 10 to 17.
40 mL of each of the obtained antiperspirant compositions of Examples 10 to 17 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
(実施例18~25)
 下記表3に示す組成及び含有量の制汗剤組成物を常法により調製した。
 具体的には、水に(B)成分を投入して均一溶解させた後、(A)成分を投入し、均一に溶解した。その後、(C)成分を均一に溶解させた(G)成分、及び共通成分としての香料を投入して混合及び均一に溶解して実施例18~25の制汗剤組成物を得た。
 得られた実施例18~25の各制汗剤組成物は、実施例1~9及び比較例1~5と同様の仕様のロールオン容器に40mL充填した。
(Examples 18 to 25)
Antiperspirant compositions having the composition and content shown in Table 3 below were prepared by a conventional method.
Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, the component (G) in which the component (C) was uniformly dissolved and the fragrance as a common component were added and mixed and uniformly dissolved to obtain an antiperspirant composition of Examples 18 to 25.
40 mL of each of the obtained antiperspirant compositions of Examples 18 to 25 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
(実施例26~29)
 下記表4に示す組成及び含有量の制汗剤組成物を常法により調製した。
 具体的には、水に(B)成分を投入して均一溶解させた後、(A)成分を投入し、均一に溶解した。その後、(D)成分を投入し、均一に溶解させた後、(C)成分を均一に溶解させた(G)成分、及び共通成分としての香料を投入して混合及び均一に溶解して実施例26~29の制汗剤組成物を得た。
 得られた実施例26~29の各制汗剤組成物は、実施例1~9及び比較例1~5と同様の仕様のロールオン容器に40mL充填した。
(Examples 26 to 29)
Antiperspirant compositions having the composition and content shown in Table 4 below were prepared by a conventional method.
Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, the component (D) was added and uniformly dissolved, and then the component (G) in which the component (C) was uniformly dissolved and the fragrance as a common component were added and mixed and uniformly dissolved. The antiperspirant compositions of Examples 26-29 were obtained.
40 mL of each of the obtained antiperspirant compositions of Examples 26 to 29 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
(実施例30~41)
 下記表5及び6に示す組成及び含有量の制汗剤組成物を常法により調製した。
 具体的には、水に(B)成分を投入して均一溶解させた後、(A)成分を投入し、均一に溶解した。その後、(E)成分を投入して均一溶解させた後、(C)成分及び(F)成分を均一に溶解させた(G)成分と、共通成分としての香料とを投入して混合及び均一に溶解して実施例30~41の制汗剤組成物を得た。
 得られた実施例30~41の各制汗剤組成物は、実施例1~9及び比較例1~5と同様の仕様のロールオン容器に40mL充填した。
(Examples 30 to 41)
Antiperspirant compositions having the compositions and contents shown in Tables 5 and 6 below were prepared by a conventional method.
Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. Then, after the component (E) was added and uniformly dissolved, the component (G) in which the components (C) and (F) were uniformly dissolved and the fragrance as a common component were added and mixed and uniformly dissolved. To obtain the antiperspirant compositions of Examples 30 to 41.
40 mL of each of the obtained antiperspirant compositions of Examples 30 to 41 was filled in a roll-on container having the same specifications as those of Examples 1 to 9 and Comparative Examples 1 to 5.
 調製した実施例1~41及び比較例1~5の制汗剤組成物(ロールオンタイプ)について、以下に記載の評価方法で、「制汗効果」、「肌のつっぱり感のなさ」、及び「剤の外観」を評価した。実施例26~29の制汗剤組成物(ロールオンタイプ)については、以下に記載の評価方法で、更に「防臭効果」及び「さらさら感」を評価した。実施例30~41の制汗剤組成物(ロールオンタイプ)については、以下に記載の評価方法で、更に「高温保存安定性」、「乾燥後のべたつきのなさ」、及び「乾燥後の見た目の自然さ」を評価した。結果を下記表1~表7に示した。 With respect to the prepared antiperspirant compositions (roll-on type) of Examples 1 to 41 and Comparative Examples 1 to 5, "antiperspirant effect", "no skin tension", and "non-tightening skin" were evaluated by the evaluation methods described below. The appearance of the agent was evaluated. For the antiperspirant compositions (roll-on type) of Examples 26 to 29, the "deodorant effect" and the "smooth feeling" were further evaluated by the evaluation methods described below. For the antiperspirant compositions (roll-on type) of Examples 30 to 41, the evaluation methods described below were used to further "high temperature storage stability", "non-stickiness after drying", and "appearance after drying". "Naturality" was evaluated. The results are shown in Tables 1 to 7 below.
<制汗効果>
 専門パネラー6名の一方の脇下に、実施例1~41及び比較例1~5の各制汗剤組成物0.40gを塗布し、乾燥させた。他方の脇下は、コントロール(制汗剤組成物未塗布)とした。その後、汗取りパッドを両脇に装着し、高温条件下(38℃、40%RH環境下)でフィットネスバイクによる運動を20分間実施した。制汗剤組成物塗布部及び制汗剤組成物未塗布部の発汗量を、それぞれ汗取りパッドの重量変化から測定した。下記式(1)に基づき制汗率を求め、専門パネラー6名の制汗率の平均値を算出した。制汗率の平均値から、下記評価基準に基づいて、「制汗効果」を評価した。
  制汗率(%)=100-制汗剤組成物塗布部の発汗量/制汗剤組成物未塗布部の発汗量×100 ・・・ 式(1)
 -「制汗効果」の評価基準-
 ◎◎ : 制汗率の平均値が65%以上100%以下
  ◎ : 制汗率の平均値が55%以上65%未満
  ○ : 制汗率の平均値が45%以上55%未満
  △ : 制汗率の平均値が10%以上45%未満
  × : 制汗率の平均値が0%以上10%未満
<Antiperspirant effect>
0.40 g of each antiperspirant composition of Examples 1 to 41 and Comparative Examples 1 to 5 was applied to one armpit of six specialized panelists and dried. The other armpit was controlled (no antiperspirant composition applied). Then, sweat pads were attached to both sides, and exercise on a fitness bike was carried out for 20 minutes under high temperature conditions (38 ° C., 40% RH environment). The amount of perspiration in the antiperspirant composition coated portion and the antiperspirant composition unapplied portion was measured from the weight change of the sweat absorbing pad, respectively. The antiperspirant rate was calculated based on the following formula (1), and the average value of the antiperspirant rate of 6 specialized panelists was calculated. The "antiperspirant effect" was evaluated from the average value of the antiperspirant rate based on the following evaluation criteria.
Antiperspirant rate (%) = 100-Amount of perspiration in the area where the antiperspirant composition is applied / Amount of perspiration in the area where the antiperspirant composition is not applied x 100 ... Equation (1)
-Evaluation criteria for "antiperspirant effect"-
◎ ◎: Average value of antiperspirant rate is 65% or more and 100% or less ◎: Average value of antiperspirant rate is 55% or more and less than 65% ○: Average value of antiperspirant rate is 45% or more and less than 55% △: Antiperspirant Average rate is 10% or more and less than 45% ×: Average antiperspirant rate is 0% or more and less than 10%
<肌のつっぱり感のなさ>
 専門パネラー20名の脇下に、実施例1~41及び比較例1~5の各制汗剤組成物0.40gを塗布し、乾燥させた後、下記評価基準に基づいて、「肌のつっぱり感のなさ」を評価した。
 -「肌のつっぱり感のなさ」の評価基準-
 ◎◎ : 専門パネラー20名中18名以上20名以下が「肌のつっぱり感がない」と回答
  ◎ : 専門パネラー20名中15名以上17名以下が「肌のつっぱり感がない」と回答
  ○ : 専門パネラー20名中11名以上14名以下が「肌のつっぱり感がない」と回答
  △ : 専門パネラー20名中6名以上10名以下が「肌のつっぱり感がない」と回答
  × : 専門パネラー20名中5名以下が「肌のつっぱり感がない」と回答
<No feeling of tension on the skin>
0.40 g of each antiperspirant composition of Examples 1 to 41 and Comparative Examples 1 to 5 was applied to the armpits of 20 specialized panelists, dried, and then "skin tension" was applied based on the following evaluation criteria. "No feeling" was evaluated.
-Evaluation criteria for "no skin tension"-
◎ ◎: 18 to 20 out of 20 specialized panelists answered “no skin tension” ◎: 15 to 17 out of 20 specialized panelists answered “no skin tension” ○ : 11 to 14 out of 20 specialized panelists answered "no skin tension" △: 6 to 10 specialized panelists answered "no skin tension" ×: Specialty Less than 5 out of 20 panelists answered that "the skin does not feel taut"
<剤の外観>
 実施例1~41及び比較例1~5の各制汗剤組成物をガラスバイアル瓶に50g入れ、室温(25℃)下で外観を観察し、下記評価基準に基づいて、「剤の外観」を評価した。
 -「剤の外観」の評価基準-
 ◎◎ : 剤の外観が非常に良い(透明の液状である)
  ◎ : 剤の外観が良い(やや半透明の液状である)
  ○ : 剤の外観がやや良い(半透明の液状である)
  △ : 剤の外観がやや悪い(白濁した液状である)
  × : 剤の外観が悪い(析出物が沈殿した液状である)
<Appearance of agent>
50 g of each antiperspirant composition of Examples 1 to 41 and Comparative Examples 1 to 5 was placed in a glass vial, the appearance was observed at room temperature (25 ° C.), and the “appearance of the agent” was based on the following evaluation criteria. Was evaluated.
-Evaluation criteria for "appearance of agent"-
◎ ◎: The appearance of the agent is very good (clear liquid)
◎: Good appearance of the agent (slightly translucent liquid)
○: The appearance of the agent is slightly good (it is a translucent liquid).
Δ: The appearance of the agent is slightly poor (it is a cloudy liquid).
×: The appearance of the agent is poor (precipitate is a precipitated liquid).
<防臭効果>
 専門パネラー8名の脇下に、実施例26~29の各制汗剤組成物0.40gを塗布し、乾燥させた。その後、高温条件下(38℃、40%RH環境下)でフィットネスバイクによる運動を20分間実施した。制汗剤組成物の塗布から20時間後、脇下部の臭気を、以下の6段階臭気強度表示法により評価した。専門パネラー8名の臭気強度の平均値を算出した。臭気強度の平均値から、下記評価基準に基づいて、「防臭効果」を評価した。
 -6段階臭気強度表示法-
 0点 : 無臭
 1点 : やっと感知できる臭い
 2点 : 何の臭いであるかわかる弱い臭い
 3点 : 楽に感知できる臭い
 4点 : 強い臭い
 5点 : 強烈な臭い
 -「防臭効果」の評価基準-
 ◎ : 臭気強度の平均値が0点以上2点未満
 ○ : 臭気強度の平均値が2点以上3点未満
 △ : 臭気強度の平均値が3点以上4点未満
 × : 臭気強度の平均値が4点以上5点以下
<Deodorant effect>
0.40 g of each antiperspirant composition of Examples 26 to 29 was applied to the armpits of eight specialized panelists and dried. Then, exercise on a fitness bike was carried out for 20 minutes under high temperature conditions (38 ° C., 40% RH environment). Twenty hours after the application of the antiperspirant composition, the odor of the lower armpit was evaluated by the following six-step odor intensity display method. The average value of the odor intensity of eight specialized panelists was calculated. The "deodorant effect" was evaluated from the average value of the odor intensity based on the following evaluation criteria.
-6-step odor intensity display method-
0 points: Odorless 1 point: Smell that can be finally detected 2 points: Weak odor that can be understood what the odor is 3 points: Smell that can be easily detected 4 points: Strong odor 5 points: Strong odor-Evaluation criteria for "deodorant effect"-
◎: Average value of odor intensity is 0 points or more and less than 2 points ○: Average value of odor intensity is 2 points or more and less than 3 points △: Average value of odor intensity is 3 points or more and less than 4 points ×: Average value of odor intensity is 4 points or more and 5 points or less
<さらさら感>
 専門パネラー30名の一方の脇下に、実施例26~29の各制汗剤組成物0.40gを塗布し、乾燥させた。他方の脇下は、コントロール(制汗剤組成物未塗布)とした。皮膚のさらさら感について、各専門パネラーが、制汗剤組成物の塗布から8時間後に、制汗剤組成物塗布部がコントロール(制汗剤組成物未塗布部)よりも明らかにさらさらすると感じた場合を「さらさら感に優れる」とし、下記評価基準に基づいて、「さらさら感」を評価した。
 -「さらさら感」の評価基準-
  ◎ : 専門パネラー30名中25名以上30名以下が「さらさら感に優れる」と回答
  ○ : 専門パネラー30名中20名以上24名以下が「さらさら感に優れる」と回答
  △ : 専門パネラー30名中10名以上19名以下が「さらさら感に優れる」と回答
  × : 専門パネラー30名中9名以下が「さらさら感に優れる」と回答
<Smooth feeling>
0.40 g of each antiperspirant composition of Examples 26 to 29 was applied to one armpit of 30 specialized panelists and dried. The other armpit was controlled (no antiperspirant composition applied). Regarding the silky feel of the skin, each specialized panelist felt that the antiperspirant composition applied portion was clearly more silky than the control (antiperspirant composition unapplied portion) 8 hours after the application of the antiperspirant composition. The case was defined as "excellent in smoothness", and "smoothness" was evaluated based on the following evaluation criteria.
-Evaluation criteria for "smoothness"-
◎: 25 or more and 30 or less of the 30 specialized panelists answered that they had an excellent smooth feeling ○: 20 or more and 24 or less of the 30 specialized panelists answered that they had an excellent smooth feeling △: 30 specialized panelists 10 or more and 19 or less responded that "excellent smoothness" ×: 9 or less of 30 specialized panelists answered that "excellent smoothness"
<高温保存安定性>
 実施例30~41の各制汗剤組成物をガラスバイアル瓶に50g入れ、50℃にて1か月で静置した後、外観を観察し、下記評価基準に基づいて、「高温保存安定性」を評価した。
 -「高温保存安定性」の評価基準-
 ◎◎:高温保存安定性が非常に良い(異物が全くない)
  ◎:高温保存安定性が良い(析出物が気液界面にごくわずかにある)
  ○:高温保存安定性がやや良い(析出物が気液界面にややある)
  △:高温保存安定性がやや悪い(析出物が気液界面にある)
  ×:高温保存安定性が悪い(析出物が気液表面から剥がれ落ちるほど大きい)
<High temperature storage stability>
50 g of each antiperspirant composition of Examples 30 to 41 was placed in a glass vial, allowed to stand at 50 ° C. for 1 month, and then the appearance was observed. Based on the following evaluation criteria, "high temperature storage stability" was observed. Was evaluated.
-Evaluation criteria for "high temperature storage stability"-
◎ ◎: Very good high temperature storage stability (no foreign matter)
⊚: Good high temperature storage stability (precipitates are very small at the gas-liquid interface)
◯: Slightly good high-temperature storage stability (precipitates slightly at the gas-liquid interface)
Δ: Slightly poor high-temperature storage stability (precipitates are at the gas-liquid interface)
X: Poor high-temperature storage stability (large enough for the precipitate to peel off from the gas-liquid surface)
<乾燥後のべたつきのなさ>
 専門パネラー20名の一方の脇下に、実施例30~41の各制汗剤組成物0.40gを塗布し、乾燥させた後、下記評価基準に基づいて、「乾燥後のべたつきのなさ」を評価した。
 -「乾燥後のべたつきのなさ」の評価基準-
  ◎ :専門パネラー20名中16名以上20名以下が、べたつきがないと回答
  ○ :専門パネラー20名中11名以上15名以下が、べたつきがないと回答
  △ :専門パネラー20名中6名以上10名以下が、べたつきがないと回答
  × :専門パネラー20名中5名以下が、べたつきがないと回答
<Non-stickiness after drying>
0.40 g of each antiperspirant composition of Examples 30 to 41 was applied to one armpit of 20 specialized panelists, dried, and then "non-sticky after drying" based on the following evaluation criteria. Was evaluated.
-Evaluation criteria for "non-stickiness after drying"-
◎: 16 to 20 out of 20 specialized panelists answered that they were not sticky ○: 11 to 15 out of 20 specialized panelists answered that they were not sticky △: 6 or more out of 20 specialized panelists 10 or less responded that they were not sticky ×: 5 or less of 20 specialized panelists answered that they were not sticky
<乾燥後の見た目の自然さ>
 専門パネラー20名の一方の脇下に、実施例30~41の各制汗剤組成物0.40gを塗布し、乾燥させた後、下記評価基準に基づいて、「乾燥後の見た目の自然さ」を評価した。
 -「乾燥後の見た目の自然さ」の評価基準-
  ◎ :専門パネラー20名中16名以上20名以下が、見た目が自然であると回答
  ○ :専門パネラー20名中11名以上15名以下が、見た目が自然であると回答
  △ :専門パネラー20名中6名以上10名以下が、見た目が自然であると回答
  × :専門パネラー20名中5名以下が、見た目が自然であると回答
<Natural appearance after drying>
0.40 g of each antiperspirant composition of Examples 30 to 41 was applied to one armpit of 20 specialized panelists, dried, and then, based on the following evaluation criteria, "naturalness of appearance after drying". Was evaluated.
-Evaluation criteria for "natural appearance after drying"-
◎: 16 or more and 20 or less of 20 specialized panelists answered that they look natural ○: 11 or more and 15 or less of 20 specialized panelists answered that they look natural △: 20 specialized panelists 6 or more and 10 or less responded that the appearance was natural ×: 5 or less of the 20 specialized panelists answered that the appearance was natural
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
(処方例1~5)
 下記表8に示す組成及び含有量の制汗剤組成物を常法により調製した。
 具体的には、水に(B)成分を投入して均一溶解させた後、(A)成分を投入し、均一に溶解した。その後、(D)成分及び(E)成分を投入し、均一に溶解させた後、(C)成分及び(F)成分を均一に溶解させた(G)成分と、共通成分としての香料とを投入して混合及び均一に溶解して処方例1~5の制汗剤組成物を得た。
 得られた各制汗剤組成物は、実施例1~9及び比較例1~5と同様の仕様のロールオン容器に40mL充填した。
(Prescription examples 1 to 5)
Antiperspirant compositions having the composition and content shown in Table 8 below were prepared by a conventional method.
Specifically, the component (B) was added to water and uniformly dissolved, and then the component (A) was added and uniformly dissolved. After that, the components (D) and (E) were added and uniformly dissolved, and then the component (G) in which the components (C) and (F) were uniformly dissolved and the fragrance as a common component were added. It was added and mixed and uniformly dissolved to obtain an antiperspirant composition of Formulation Examples 1 to 5.
40 mL of each of the obtained antiperspirant compositions was filled in a roll-on container having the same specifications as in Examples 1 to 9 and Comparative Examples 1 to 5.
 調製した処方例1~5の制汗剤組成物(ロールオンタイプ)について、実施例26~41と同様の評価方法で、「制汗効果」、「肌のつっぱり感のなさ」、「剤の外観」、「高温保存安定性」、「防臭効果」、「さらさら感」、「乾燥後のべたつきのなさ」、及び「乾燥後の見た目の自然さ」を評価した。結果を下記表8に示した。 The prepared antiperspirant compositions (roll-on type) of Formulation Examples 1 to 5 were evaluated by the same evaluation method as in Examples 26 to 41, and had "antiperspirant effect", "no skin tension", and "appearance of the agent". , "High temperature storage stability", "deodorant effect", "smoothness", "non-stickiness after drying", and "natural appearance after drying" were evaluated. The results are shown in Table 8 below.
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
 前記実施例、比較例、及び処方例で使用した各成分の詳細について、下記表9に示す。 Details of each component used in the above-mentioned Examples, Comparative Examples, and Formulation Examples are shown in Table 9 below.
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
 本発明の態様としては、例えば、以下のものなどが挙げられる。
 <1> (A)ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分と、
 (B)対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩と、
を含有し、
 前記(A)成分の含有量と前記(B)成分の含有量との質量比(A)/(B)が5~20であることを特徴とする制汗剤組成物である。
 <2> (C)アルキル基の炭素数が1~4のマレイン酸モノアルキル、アルキル基の炭素数が1~8のアルキルアクリルアミド、ジアセトンアクリルアミド、ビニルピロリドン、及びメタクリル酸エチルベタインから選択される少なくとも1種をモノマー単位として含む共重合体又はその塩、及び
 (G)エタノール、
を更に含有する前記<1>に記載の制汗剤組成物である。
 <3> (E)疎水化アルキル変性アルキルセルロース、及び
 (F)コハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種、
を更に含有する前記<2>に記載の制汗剤組成物である。
 <4> 前記(B)成分の含有量と前記(E)成分の含有量との質量比(B)/(E)が2.1~10である前記<3>に記載の制汗剤組成物である。
 <5> (D)ヒドロキシアルキル化シクロデキストリンを含有する前記<1>から<4>のいずれかに記載の制汗剤組成物である。
 <6> (B)成分が、硫酸塩、炭酸塩、及び塩酸塩から選択される少なくとも1種である前記<1>から<5>のいずれかに記載の制汗剤組成物である。
 <7> (C)成分が、(アクリレーツ/ジアセトンアクリルアミド)コポリマーAMP、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー、及び(ビニルメチルエーテル/マレイン酸エチル)コポリマーから選択される少なくとも1種である前記<2>から<6>のいずれかに記載の制汗剤組成物である。
Examples of aspects of the present invention include the following.
<1> (A) At least one antiperspirant component selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate.
(B) A water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a counter ion.
Contains,
The antiperspirant composition is characterized in that the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is 5 to 20.
<2> (C) Selected from monoalkyl maleate having 1 to 4 carbon atoms in the alkyl group, alkylacrylamide having 1 to 8 carbon atoms in the alkyl group, diacetoneacrylamide, vinylpyrrolidone, and ethylbetaine methacrylate. A copolymer containing at least one type as a monomer unit or a salt thereof, and (G) ethanol,
The antiperspirant composition according to <1>, which further contains.
<3> (E) Hydrophobicized alkyl-modified alkyl cellulose, and (F) at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid.
The antiperspirant composition according to <2>, which further contains.
<4> The antiperspirant composition according to <3>, wherein the mass ratio (B) / (E) of the content of the component (B) to the content of the component (E) is 2.1 to 10. It is a thing.
<5> The antiperspirant composition according to any one of <1> to <4>, which contains (D) hydroxyalkylated cyclodextrin.
<6> The antiperspirant composition according to any one of <1> to <5>, wherein the component (B) is at least one selected from sulfate, carbonate, and hydrochloride.
<7> The components (C) are (Acrylate / Diacetone Acrylamide) Copolymer AMP, (Acrylate / Alkyl Acrylate (C1-18) / Alkyl (C1-8) Acrylamide) Copolymer, and (Vinyl Methyl Ether / Ethyl Maleate). ) The antiperspirant composition according to any one of <2> to <6>, which is at least one selected from the copolymer.
 本発明の制汗剤組成物は、制汗効果及び肌のつっぱり感のなさに優れ、更に剤の外観が良好であるため、化粧料、医薬品、医薬部外品等に幅広く用いることができ、制汗剤、防臭剤、制汗防臭剤、デオドラント剤により好適に用いることができる。 The antiperspirant composition of the present invention is excellent in antiperspirant effect and lack of tension on the skin, and has a good appearance, so that it can be widely used in cosmetics, pharmaceuticals, non-pharmaceutical products, and the like. It can be preferably used by an antiperspirant, a deodorant, an antiperspirant deodorant, and a deodorant.

Claims (7)

  1.  (A)ハロゲン化アルミニウム、ハロゲン化アルミニウム水和物、及びハロゲン化アルミニウム水和物の錯体から選択される少なくとも1種の制汗成分と、
     (B)対イオンとしてアルカリ金属イオン、バリウムイオン、及びマグネシウムイオンから選択される少なくとも1種を有するアルミニウム塩以外の水溶性無機塩と、
    を含有し、
     前記(A)成分の含有量と前記(B)成分の含有量との質量比(A)/(B)が5~20であることを特徴とする制汗剤組成物。
    (A) At least one antiperspirant component selected from a complex of aluminum halide, aluminum halide hydrate, and aluminum halide hydrate.
    (B) A water-soluble inorganic salt other than an aluminum salt having at least one selected from alkali metal ion, barium ion, and magnesium ion as a counter ion.
    Contains,
    An antiperspirant composition, wherein the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is 5 to 20.
  2.  (C)アルキル基の炭素数が1~4のマレイン酸モノアルキル、アルキル基の炭素数が1~8のアルキルアクリルアミド、ジアセトンアクリルアミド、ビニルピロリドン、及びメタクリル酸エチルベタインから選択される少なくとも1種をモノマー単位として含む共重合体又はその塩、及び
     (G)エタノール、
    を更に含有する請求項1に記載の制汗剤組成物。
    (C) At least one selected from monoalkyl maleate having 1 to 4 carbon atoms in the alkyl group, alkyl acrylamide having 1 to 8 carbon atoms in the alkyl group, diacetone acrylamide, vinyl pyrrolidone, and ethyl betaine methacrylate. A copolymer containing the above as a monomer unit or a salt thereof, and (G) ethanol,
    The antiperspirant composition according to claim 1, further comprising.
  3.  (E)疎水化アルキル変性アルキルセルロース、及び
     (F)コハク酸ビスエトキシジグリコール及びシクロヘキサンジカルボン酸ビスエトキシジグリコールから選択される少なくとも1種、
    を更に含有する請求項2に記載の制汗剤組成物。
    (E) Hydrophobicized alkyl-modified alkyl cellulose, and (F) at least one selected from bisethoxydiglycol succinate and bisethoxydiglycol cyclohexanedicarboxylic acid.
    The antiperspirant composition according to claim 2, further comprising.
  4.  前記(B)成分の含有量と前記(E)成分の含有量との質量比(B)/(E)が2.1~10である請求項3に記載の制汗剤組成物。 The antiperspirant composition according to claim 3, wherein the mass ratio (B) / (E) of the content of the component (B) to the content of the component (E) is 2.1 to 10.
  5.  (D)ヒドロキシアルキル化シクロデキストリンを含有する請求項1から4のいずれかに記載の制汗剤組成物。 (D) The antiperspirant composition according to any one of claims 1 to 4, which contains hydroxyalkylated cyclodextrin.
  6.  (B)成分が、硫酸塩、炭酸塩、及び塩酸塩から選択される少なくとも1種である請求項1から5のいずれかに記載の制汗剤組成物。 The antiperspirant composition according to any one of claims 1 to 5, wherein the component (B) is at least one selected from sulfate, carbonate, and hydrochloride.
  7.  (C)成分が、(アクリレーツ/ジアセトンアクリルアミド)コポリマーAMP、(アクリレーツ/アクリル酸アルキル(C1-18)/アルキル(C1-8)アクリルアミド)コポリマー、及び(ビニルメチルエーテル/マレイン酸エチル)コポリマーから選択される少なくとも1種である請求項2から6のいずれかに記載の制汗剤組成物。 The component (C) is from the (Acrylate / Diacetoneacrylamide) copolymer AMP, the (Acrylate / Alkyl acrylate (C1-18) / Alkyl (C1-8) acrylamide) copolymer, and the (Vinylmethyl ether / Ethyl maleate) copolymer. The antiperspirant composition according to any one of claims 2 to 6, which is at least one selected.
PCT/JP2020/037919 2019-10-31 2020-10-06 Antiperspirant composition WO2021085059A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021554246A JPWO2021085059A1 (en) 2019-10-31 2020-10-06

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019198333 2019-10-31
JP2019-198333 2019-10-31

Publications (1)

Publication Number Publication Date
WO2021085059A1 true WO2021085059A1 (en) 2021-05-06

Family

ID=75715233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/037919 WO2021085059A1 (en) 2019-10-31 2020-10-06 Antiperspirant composition

Country Status (2)

Country Link
JP (1) JPWO2021085059A1 (en)
WO (1) WO2021085059A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050152861A1 (en) * 2001-11-17 2005-07-14 Stefan Bruening Cosmetic antiperspirant roll-on formulations based on a w/o emulsion
JP2013147505A (en) * 2006-05-11 2013-08-01 Air Products & Chemicals Inc Personal care composition containing functionalized polymer
JP2017222615A (en) * 2016-06-16 2017-12-21 ライオン株式会社 Antiperspirant composition
JP2019156815A (en) * 2018-03-16 2019-09-19 株式会社マンダム Antiperspirant composition, and antiperspirant
JP2019156813A (en) * 2018-03-16 2019-09-19 株式会社マンダム Antiperspirant composition, and antiperspirant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050152861A1 (en) * 2001-11-17 2005-07-14 Stefan Bruening Cosmetic antiperspirant roll-on formulations based on a w/o emulsion
JP2013147505A (en) * 2006-05-11 2013-08-01 Air Products & Chemicals Inc Personal care composition containing functionalized polymer
JP2017222615A (en) * 2016-06-16 2017-12-21 ライオン株式会社 Antiperspirant composition
JP2019156815A (en) * 2018-03-16 2019-09-19 株式会社マンダム Antiperspirant composition, and antiperspirant
JP2019156813A (en) * 2018-03-16 2019-09-19 株式会社マンダム Antiperspirant composition, and antiperspirant

Also Published As

Publication number Publication date
JPWO2021085059A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
JP4072458B2 (en) Aqueous composition for cosmetics and cosmetics comprising the same
JP6070571B2 (en) Deodorant composition
US9402798B2 (en) Carrageenan mixtures useful as cosmetic ingredients and hair styling gels comprising them
JP5876296B2 (en) Gel-like composition
JP2017048140A (en) Antiperspirant composition
JP3016773B2 (en) Solid cosmetic composition and use thereof
AU2014339280B2 (en) Anti-perspirant composition
JP3845203B2 (en) Gel hair conditioner
JP6900122B2 (en) Antiperspirant composition and antiperspirant
KR100418551B1 (en) Cosmetics for the arrangement of hair and method for the arrangement of hair using them
WO2021085059A1 (en) Antiperspirant composition
JP6900121B2 (en) Antiperspirant composition and antiperspirant
JP6660258B2 (en) Antiperspirant composition
JP7009088B2 (en) Antiperspirant composition
JP7101097B2 (en) Antiperspirant composition
JP6909353B2 (en) Powder-containing external preparation for skin
JP2022080515A (en) Antiperspirant composition
WO2019176265A1 (en) Antiperspirant composition, and antiperspirant
JP2000355518A (en) Gel cosmetic
EP3374032A1 (en) Anti-perspirant composition
JP2022096800A (en) Antiperspirant composition
JP2022144479A (en) Body odor inhibitor
WO2024115566A1 (en) Process for treating human perspiration and associated kit
JP2023153449A (en) Wrinkle inhibitor and skin cosmetics including wrinkle inhibitor
JP2022050173A (en) Antiperspirant composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20880758

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021554246

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20880758

Country of ref document: EP

Kind code of ref document: A1